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Abstract of the Dissertation 
 
Exploring the Complexities of Real World Upper Limb Performance after Stroke  
by 
Kimberly J. Waddell 
Doctor of Philosophy in Movement Science 
Washington University in St. Louis, 2019 
Professor Catherine E. Lang, Chair 
 
 
Stroke is the leading cause of long-term disability in the United States. Hemiparesis, or weakness 
on one side of the body, is a common impairment following a stroke. Approximately 80% of 
individuals with stroke will experience upper limb paresis, with only a small percentage 
regaining full functional use of their paretic upper limb. Individuals report ongoing difficulties 
with incorporating their paretic upper limb into routine activities after a stroke. Rehabilitation 
interventions often try to increase real world upper limb use by improving what an individual is 
capable of doing (i.e. capacity) in the rehabilitation clinic. Both clinicians and researchers 
assume that improving in-clinic capacity translates to increased use (i.e. performance) in daily 
life. For this dissertation, we explicitly tested the assumption that improved upper limb capacity 
translates to increased upper limb performance, or use, in daily life. Additionally, we explored 
known factors that influence human behavior (e.g. confidence, motivation) as they relate to 
upper limb performance, or use, in adults with stroke.   
 
xi 
 
Using sensors (i.e. wrist-worn accelerometers), we tested the assumption that improved in-clinic 
upper limb capacity translates to increased upper limb performance, or use, in daily life in adults 
with chronic (≥ 6 months) upper limb paresis post-stroke. Testing this common assumption 
provided important insights into the efficacy of an in-clinic intervention for improving upper 
limb use in the free-living environment.    
 
Many personal, environmental, biological, and psychosocial factors influence human behavior 
and the activities individuals choose to engage in throughout their day. There is a growing 
emphasis on the potentially powerful role self-efficacy and other psychosocial factors may play 
in the stroke recovery process. Currently, there are limited data on how psychosocial factors, 
specifically related to the upper limb, evolve over the critical period of motor recovery (< 6 
months post-stroke). Here, we quantified the natural time course of belief further improvement 
of the paretic upper limb is possible, confidence, and motivation to use the paretic upper limb in 
daily life, as well as self-reported barriers to upper limb recovery. These data provide a more 
robust understanding of how psychosocial factors evolve as overall recovery improves. 
Additionally, these data provide important information about potential mechanisms for action for 
future upper limb interventions. 
 
The final project of this dissertation maps the natural trajectory of upper limb performance over 
the first 12 weeks post-stroke. Presently, no studies have examined the natural trajectory of 
sensor-measured upper limb performance over the same period of time when majority of upper 
limb motor recovery occurs. We sought to characterize the relationship between upper limb 
xii 
 
performance and psychosocial factors by testing belief, confidence, and motivation as potential 
moderators of upper limb performance in daily life. 
  
The reported findings show that in-clinic improvements in upper limb capacity do not directly 
translate to increased upper limb performance, or use, in daily life in the chronic phase of stroke 
recovery. Indeed, improving what someone is capable of doing does not indicate their behavior 
will change in daily life. These results help distinguish between upper limb capacity and upper 
limb performance. While conceptually similar, they are distinct constructs. Belief, confidence, 
and motivation to use the paretic upper limb in daily life are remarkably high early, and remain 
high over the first 24 weeks (6 months) post-stroke. Upper limb performance in daily life does 
improve early (<12 weeks) after stroke. This change, however, is not moderated by belief, 
confidence, and motivation. Together, this dissertation provides multi-dimensional information 
related to upper limb performance after stroke. These results will lead to a more integrated 
approach for optimizing upper limb performance outcomes, a top priority for people post-stroke.       
 
1 
 
Chapter 1: Introduction  
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This introductory chapter begins with an overview of stroke and its increasing burden on the 
United States healthcare system and survivors. It then transitions to a thorough discussion of 
capacity and performance, two terms defined by the International Classification of Functioning 
Framework,1 that are used throughout this thesis. Specific emphasis is placed on how upper limb 
capacity and performance are measured after stroke, and the corresponding limitations of these 
measures. Next, there is a discussion related to the importance of examining the natural 
trajectory of both UL use in daily life and related psychosocial factors early after stroke. Three 
psychosocial factors (belief, confidence, and motivation) are introduced.  Finally, belief, 
confidence, and motivation, as well as self-perceived barriers to UL recovery are proposed as 
potential mechanisms that may moderate UL use in daily life early after a stroke.   
1.1 Stroke is expensive and a significant health problem 
Stroke is the leading cause of complex, long-term disability.2-4 Every 40 seconds, someone in the 
United States will experience a stroke.3 With the increasing aging population in the United 
States, the incidence of stroke is projected to rise in the coming years.2 The United States spends 
approximately $40.1 billion healthcare dollars annually on direct and indirect stroke care.2,3 By 
2035, projected stroke costs in the United States will more than double from $40.1 billion to 
$94.3 billion.2 Advances in acute medical care have reduced the overall stroke mortality rate.2,3,5 
As a result, more individuals are surviving a stroke but living with chronic, long-term disability. 
The increasing number of survivors with motor, cognitive, and psychological/emotional deficits 
creates an urgent need for streamlined medical and rehabilitation services to help improve 
medical care and reduce stroke-related disability. 
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Nearly 80% of stroke survivors will experience some degree of upper limb (UL) paresis.6 
Recovery of UL function is relatively poor, with only 5 to 20% of individuals regaining full 
function of the paretic UL.7 At just 6 months post-stroke, nearly 65% of survivors report 
difficulty incorporating their paretic UL into everyday tasks.8 The ongoing deficits in UL 
function can limit performance in daily life. For example, at 6 months after stroke, 57% of 
survivors report discontinuing meaningful activities in their everyday life.9 Over a 24-hour 
period, healthy, neurologically intact adults use their two hands together 95% of the time.10 The 
reported difficulty with incorporating the paretic UL into everyday tasks may be attributed, at 
least in part, to UL paresis.    
 
Individuals with stroke identified improving UL function as a top research priority for stroke 
rehabilitation.11 As a result, the research community has invested significant time and research 
dollars to develop efficacious, in-clinic UL interventions to improve UL function both early12,13 
and later14,15 after stroke. These interventions often include a secondary measure of self-reported 
UL performance, or use, in daily life (e.g. Motor Activity Log16 or Stroke Impact Scale17). Until 
recently, it was often assumed the in-clinic improvements in UL capacity directly translated to 
increased UL performance in daily life. Indeed, this ostensible assumption is partially supported 
when UL performance in daily life is quantified using self-report measures.14,18 This assumption, 
however, is not supported by emerging evidence using a direct measure of UL performance (e.g. 
wearable sensors).19-21 The assumption that improved UL capacity directly translates to increased 
UL performance has yet to be explicitly tested in adults with UL paresis post-stroke. 
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1.2 Capacity and performance: Understanding the ICF 
The World Health Organization’s International Classification of Functioning, Disability, and 
Health Framework (ICF) is a comprehensive framework for measuring both individual and 
population health.22,23 The ICF is a valuable tool for evaluating and understanding the complex 
nature of health and disability. Figure 1 outlines the three ICF domains: body 
structures/functions, activity, and participation. The ICF model emphasizes an individual’s 
health along these domains, and serves as a useful tool for understanding functional limitations 
following a health event, such as a stroke.22,24,25 Capacity and performance, two terms used 
throughout this thesis, are qualifiers of the activity domain.  
 
Figure 1.1 Adapted International Classification of Functioning, Disability, and Health 
Framework (ICF) 
1.2.1 Motor capacity 
Capacity is defined as what someone is capable of doing in a standardized, or controlled, 
environment.1,22 A standardized environment has removed the environmental barriers that may 
interfere with an individual’s ability to complete a task and provides identical testing conditions 
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for every person.1 Standardized clinical assessments quantify capacity in a clinic or laboratory 
setting. 
  
One of the most common standardized assessment of UL capacity after a stroke is the Action 
Research Arm Test (ARAT).26 Additional assessments of UL capacity include the Wolf Motor 
Function Test,27 Box and Blocks,28 Nine Hole Peg Test,29 and the Jebsen Taylor Hand Function 
Test.30 These UL capacity assessments are highly correlated with each other and also with 
measures of UL impairment,31 and provide important information related to what an individual is 
capable of doing within a controlled environment. The term impairment is associated with the 
body structure/function domain of the ICF (Figure 1). Impairment of the UL results from stroke-
related damage to cortical and subcortical brain structures. Examples of UL impairment after 
stroke include decreased range of motion and strength, poor coordination, spasticity, and sensory 
loss. Impairments are quantified using standardized assessments, such as the Fugl-Meyer, 
dynamometry, and the Modified Ashworth Scale. Upper limb capacity is also a predictor of 
participation in life roles post-stroke.32 Participation (Figure 1) is defined as involvement in a life 
situation (e.g. going to a place of worship, hiking). Individuals report limitations with 
participating in life roles over the months and years following a stroke. Common validated 
assessments of participation after stroke include the Assessment of Life Habits, Frenchay 
Activities Index, the Activity Card Sort, and the Stroke Impact Scale. 
 
One limitation of these standardized measures of UL capacity is their failure to include bilateral 
tasks as part of their design. Given the bilateral requirement (to varying degrees) of most UL 
tasks,10 it has become increasingly important to include bilateral assessments when measuring 
6 
 
UL capacity. The Chedoke Arm and Hand Activity Inventory (CAHAI)33,34 is likely the most 
common measure of bilateral UL capacity after stroke. The CAHAI is underutilized compared to 
the unilateral assessments listed above. The greatest limitation, however, is the inability of UL 
capacity measures to provide information about UL performance, or use, in the free-living 
environment.    
1.2.2 Motor performance 
Performance is defined as what a person actually does outside of the clinic or laboratory.1 
Performance, compared to capacity, is more complex for several reasons. First, a non-
standardized environment includes a combination of physical, social, and personal factors that 
either facilitate or hinder performance. These factors exist in various combinations and are not 
consistent across individuals. Second, quantifying UL performance in daily life is difficult. In 
person observation is both costly and infeasible. As a result, self-report and sensor measures are 
used to quantify perceived and actual performance, respectively.  
 
Self-report measures quantify perceived UL performance. The Motor Activity Log (MAL) is a 
common self-report measure of UL performance in daily life.16  The MAL queries individuals on 
how often (amount of use) and how well (quality of use) they used their paretic UL across 28 
everyday tasks (e.g. turn on a light, make a sandwich) over the previous week.16 The Stroke 
Impact Scale (SIS) is another common self-report measure.17 The SIS includes several subscales, 
each probing a different area of stroke recovery (e.g. mobility, communication, memory, and 
arm/hand function). The SIS-Hand scale includes five questions and asks the individual to rate 
how difficult it is to use their paretic UL for each task (e.g. turn a doorknob).17 Several studies of 
7 
 
UL rehabilitation post-stroke have reported a significant change in UL performance in daily life 
when using self-report measures.14,18,35  
 
Limitations of self-report 
Self-assessment of performance requires several cognitive processes and the ability to accurately 
recall information from the past.36 As a result, self-report measures are vulnerable to recall bias 
and/or social desirability bias, which can compromise results. Recall bias occurs when there is 
either an intentional or unintentional deviation in the recalled details of an event from what 
actually occurred.37 The magnitude of recall bias in any given study can either inflate or 
attenuate the effect size, leading to inaccurate results.37 The recall bias associated with self-report 
measures is well-documented in the physical activity literature36,38-40 and health related quality of 
life research.41 Interestingly, recall bias is greater when recall (i.e. memory) is poor.42  This is of 
particular concern in stroke rehabilitation, given the prevalence of memory impairment following 
a stroke.43-45 
 
Self-report is often limited by social desirability bias as well.46 Social desirability bias occurs 
when an individual modifies their answer due to fear of feeling embarrassed or desire to project a 
favorable image.47 Similar to recall bias, social desirability bias can lead to an inaccurate effect 
size and measurement error.47,48 Social desirability bias is common in physical activity and 
nutrition research.49,50 The ongoing threat these biases, and others, pose to self-report research 
have contributed to the development of other non-invasive, direct measures of UL performance 
post-stroke. 
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Accelerometry 
Accelerometry is a valid, reliable, non-invasive measure of direct UL performance in both 
healthy adults10,51 and adults with stroke.19,52-56 These small sensors are similar to a FitBit and 
provide answers to long-standing questions related to real time behaviors in daily life after 
stroke.57 Accelerometry records movement in terms of acceleration and quantifies various 
aspects of UL movement such as total duration of movement,10 movement of one UL compared 
to the other (bilateral information),52,54 and information about the intensity of movement.52,54 
Wrist-worn accelerometry effectively removes the burden of information recall and does not 
require individuals to estimate how often or well an activity was performed over previous days.  
 
Limitations of accelerometry  
While not vulnerable to recall or social desirability bias, wrist-worn accelerometry does not have 
the capacity to register the type of activity and distinguish between activities with similar 
kinematic profiles (e.g. typing vs. chopping vegetables). Studies are underway to identify the 
specific activities performed in daily life using accelerometer data. These studies require 
machine learning and predictive algorithms, but have limited success thus far.58-60 Additionally, 
accelerometry does not provide information about the quality of UL movement, an issue 
important to some clinicians and researchers. 
 
A substantial amount of work has exposed the discrepancy between self-report and direct 
measures with physical activity data (correlations between the two measures range from -0.7 to 
0.7).36,38-40 Emerging research suggests this discrepancy is also true in adults with spinal cord 
injury61 and stroke.62,63 While self-reported UL performance (MAL) and accelerometry are 
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moderately correlated,56,64 there is a high degree of variability and inconsistency between self-
reported UL performance and sensor measured UL performance in adults with stroke (see 
Appendix C).63 Thus, perceived and direct performance are two distinct constructs and the 
measures used to quantify both constructs cannot be used interchangeably.   
 
Personal & Environmental Factors  
Personal and environmental factors are often independent of the health condition but play a role 
in the disease process.1,22 Both personal and environmental factors can influence all domains of 
the ICF (Figure 1) and likely play a substantial role in UL performance in daily life. Personal 
factors include demographic characteristics such as age and education level in addition to 
personality factors (e.g. coping strategies), social determinants of health (e.g. socioeconomic 
status), and psychosocial factors (e.g. motivation, self-efficacy).1 Environmental factors include 
the physical, social, and attitudinal environment that serve as both barriers and facilitators to 
functioning.1,22 While personal factors are difficult to modify, some environmental factors can be 
modified in the home to help facilitate participation in life roles following a stroke.65 
 
Summary 
In summary, the ICF Framework provides a robust lens to view the interconnectedness and 
complexities of stroke related disability. All too often, rehabilitation interventions focus on 
specific domains (e.g. decreased strength, impaired memory) of the larger, complex disability. 
While not inherently wrong, this approach can leave little overlap between domains in terms of 
goals and interventions. A consequence of this may be limited understanding of how other 
factors, such as confidence and motivation, may influence outcomes. Moving forward, an 
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integrated approach to not just UL rehabilitation but all stroke rehabilitation may lead to 
improved overall outcomes. 
1.3  Trajectories of recovery 
1.3.1 Upper limb performance 
The recovery trajectories of UL impairment and capacity over the first 6 months post-stroke are 
well documented.66-70 The majority of UL impairment and capacity recovery occurs during the 
first 3 months post-stroke. The magnitude of change slows between 3-6 months and by 6 months, 
UL recovery has plateaued. Understanding the recovery trajectory of UL impairment and 
capacity helps clinicians and researchers know when the critical period of motor recovery occurs. 
This critical period is proposed as the ideal time for rehabilitation services and informs 
interventions designed to improve UL impairment or UL capacity. The recovery trajectories of 
somatosensory impairment,71 cognitive impairment,43,72 lower extremity motor capacity and 
walking,66,73 language,74 neuropsychiatric, 67 quality of life,75,76 and general illness77,78 after 
stroke have also been explored to varying degrees. To date, no research has explored the natural 
trajectory of UL performance in daily life early after stroke. 
 
The purpose of rehabilitation is to improve overall performance in daily life. The paucity of 
studies characterizing UL performance over the first weeks and months post-stroke may be a 
direct consequence of assuming improved UL capacity directly translates to increased UL 
performance. Presently, researchers do not know if UL performance can improve early after 
stroke, absent of a controlled intervention. It is important to determine if UL performance can 
improve during the first 3 months post-stroke, the critical recovery period for UL impairment 
and capacity. Mapping the natural trajectory of UL performance in daily life is important for 
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future clinical trials designed to increase UL performance in everyday tasks. Characterizing UL 
performance in daily life, however, requires thoughtful consideration of factors beyond the motor 
system, such as belief, confidence, and motivation to use the paretic UL in everyday tasks and 
self-perceived barriers to UL recovery.79,80  
1.3.2 Psychosocial factors 
To date, no research has explored how psychosocial factors, such as belief improvement of the 
paretic UL is possible, confidence, and motivation to use the paretic UL in everyday tasks, and 
self-perceived barriers to UL recovery evolve over the first 6-months post-stroke. Belief, 
confidence, and motivation are empirically derived factors from Social Cognitive Theory79,80 and 
Social Determination Theory81-83 and have received considerable attention from the rehabilitation 
community in recent years.84 The limited knowledge of these psychosocial factors comes from 
cross-sectional data in survivors who are 4-7 years post-stroke.85-87 While valuable, these data 
may differ from the early months post-stroke, especially in the presence of acute psychological 
distress that is common after sudden health events.88  Additionally, cross-sectional data cannot 
capture the inherent dynamic nature of these psychosocial factors80 and how they may change 
across the recovery process. Quantifying these factors over the first 6 months after stroke will 
provide valuable information into how these factors evolve as UL impairment and capacity, as 
well as general recovery, improves. This information will provide critical insight into when 
belief, confidence, and motivation are highest and when might be an ideal time to leverage these 
factors as part of rehabilitation interventions. In contrast, if there exists a time when these 
psychosocial factors are low, real world benefit from motor interventions may be limited. 
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Characterizing the natural time course of these psychosocial factors and self-perceived barriers to 
recovery is essential for future interventions designed to increase UL use in everyday activities. 
Belief further improvement of the paretic UL is possible, confidence, and motivation to use the 
paretic UL in everyday tasks may be potential mechanisms for action to improve UL 
performance in daily life. Additionally, addressing self-perceived barriers to UL recovery may be 
a key target for future rehabilitation interventions.  
 
Belief  
Individual belief that further improvement of the paretic UL is possible may influence the type of 
activity or amount of UL use in daily life. Belief that recovery is possible is a coping mechanism 
after stroke.89 Preliminary research suggests it may be important for treatment adherence and the 
overall stroke recovery process.85,90 Individuals with stroke identified belief in further recovery 
as a marker of a positive, or good recovery process, and the loss of belief as a marker of poor 
recovery.85 An individual may possess a strong desire to use their paretic UL in everyday tasks if 
they believe that further improvement is possible. In contrast, if an individual believes their UL 
will not improve, they may have less incentive to use their UL in everyday activities because the 
perceived benefit may be minimal. At 5 years post-stroke (when motor recovery has plateaued), 
84% of survivors believed further improvement of their paretic UL was possible.86 This 
remarkably high level of belief suggests other factors beyond the motor system (e.g. personal, 
social, environmental) may influence an individual’s belief further recovery is possible post-
stroke.  
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An individual’s perceived self-efficacy is marked by their beliefs about their capabilities to 
complete different activities and maintain control over different situations.91,92 These efficacy 
beliefs, in many ways, determine the types of activities people choose to perform.79 A person 
with high efficacy beliefs will approach activities and situations with greater confidence 
compared to someone with low efficacy beliefs.91,93 Additionally, a person who believes they 
possess the abilities to acquire the necessary skills through practice or previous skill mastery will 
also be more motivated to engage in specific activities compared to those with low efficacy 
beliefs.    
 
Confidence 
Stroke survivors identified improving confidence to perform activities as a top research 
priority.11 Confidence in one’s ability to successfully complete an activity is considered a marker 
of recovery 94 and a key predictor of performance.94,95 Individuals with greater confidence in 
their abilities are more likely to engage in activities compared to those with low confidence.94 
 
Confidence is a key component of self-efficacy.91,93 Prior success or failures substantially 
influence confidence to perform future activities. To date, very little is known about how 
confidence changes over the first 6 months following a stroke and how it may influence UL 
performance in daily life. 
 
Motivation  
Motivation is a critical component of behavior change84 and motor learning.95 Self-efficacy acts 
upon motivational processes that ultimately influence behavior.91 Motivational processes are 
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influenced by cognition, specifically forethought.91 Motivation to perform an activity is 
simultaneously influenced by one’s beliefs about their skills and abilities, the activity goal, the 
anticipated outcome, and the planned course of action.79,91 An individual will experience higher 
task-specific motivation if they are confident in their skills, have realistic goals, and believe they 
can accomplish the intended outcome with little to no difficulty.91,95  
 
Understanding how motivation to use the paretic UL in everyday life evolves over the early 
months post-stroke is important for designing future UL interventions. There is an emerging 
interest in how motivation may influence motor and behavioral outcomes post-stroke.84,96 While 
important, the first critical step is to characterize individual motivation across time. Quantifying 
the time course of motivation to use the paretic UL in everyday activities will capture its inherent 
dynamic nature.79  There may be periods in the recovery process when motivation is low and 
novel techniques to improve motivation would be required. Alternatively, when motivation is 
high, clinicians and researchers can capitalize on this to help increase overall UL performance in 
daily life. 
 
Barriers to performance 
Barriers to performance or recovery can hinder a person’s ability to engage in a meaningful 
activity. An individual with high levels of motivation or confidence to engage in an activity may 
be limited due to barriers. For example, psychosocial barriers (e.g. depression, stress level), 
personal barriers (e.g. age, educational level), social barriers (e.g. social support, family support), 
and cognitive barriers (e.g. impaired memory) are all strongly correlated with medication 
adherence.97,98 Barriers such as lack of time, access to facilities, social support, health status, 
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outcome expectancy, and individual motivation can restrict physical activity levels.99,100 After a 
stroke, individuals report environmental barriers (e.g. transportation), health status, severity of 
stroke deficits, and motivation as barriers to engaging in regular physical activity.101 Quantifying 
barriers to UL recovery after a stroke will help identify potential therapy targets for clinicians 
and researchers to address with their interventions.   
 
The paucity of studies exploring self-perceived barriers to UL performance in daily life are from 
individuals who are, on average, 4-7 years post-stroke.85-87 While important, the recovery process 
several years post-stroke is markedly different from the first few months following a stroke. For 
example, 80% of survivors will receive a referral for rehabilitation services immediately after 
their stroke.102 In the United States, rehabilitation services fade over time with few survivors 
receiving therapy at 6 months, not to mention several years post-stroke. As a result, barriers such 
as access to healthcare services that are common several years post stroke may not be as 
common early after stroke.86,87 The perceived barriers to recovery will likely be different early 
after stroke (< 6 months) during the time of rapid, notable recovery when compared to several 
years post-stroke when little recovery occurs.  
1.4 Psychosocial Factors and UL performance 
Human behavior is a dynamic process, influenced by many individual, social, and environmental 
factors.80 The choice to perform and accomplish an activity requires ongoing reflection and 
predictions about one’s ability to succeed.79 Social Cognitive Theory reflects this dynamic, 
reciprocal relationship between a person and the broad network of social and environmental 
influences that contribute to behavior.79,80,103 Self-efficacy is a key component of Social 
Cognitive Theory. Self-efficacy, characterized by belief about one’s abilities and confidence in 
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one’s skills to perform, influences many domains of stroke recovery such as physical activity,104 
balance and walking,105 independence with activities of daily living,106 onset of post-stroke 
depression,107 and overall well-being.108 Motivation, a key element of Social Determination 
Theory,81-83 has previously shown to influence motor learning95 and behavior84 and has been 
identified as a potential target for improving rehabilitation outcomes post-stroke.96,109 Presently, 
there are no available data to describe the potential relationship between these psychosocial 
factors (belief, confidence, and motivation) and UL performance in daily life.  
 
If these psychosocial factors moderate UL performance in daily life in the early months post-
stroke, then future interventions specifically targeting these factors are warranted. With the 
growing emphasis on belief, confidence, and motivation as a means to improve performance in 
daily life, this will be the first experiment to explicitly test if UL performance is moderated by 
psychosocial factors early after stroke. 
 
Summary 
Together, characterizing how belief further improvement of the paretic UL is possible, 
confidence and motivation to use the paretic UL in everyday tasks, and self-perceived barriers to 
recovery evolve over the first 6 months post-stroke will provide a more holistic understanding of 
UL performance in daily life. Additionally, this will be the first study to quantify these factors 
during the period of time when majority of recovery occurs. This, combined with the 
uncertainties of how UL capacity and performance are related, led to the proposed aims for this 
dissertation. 
17 
 
1.5  Specific Aims 
Aim 1: Examine the translation of in-clinic UL capacity gains to increased UL performance 
in daily life. This is a secondary analysis from a Phase II clinical dose-response trial in a chronic 
(≥ 6 months) stroke cohort.  
Hypothesis 1a: Individuals with significant UL capacity gains will demonstrate increased UL 
performance in daily life compared to individuals with insignificant capacity gains. 
Hypothesis 1b: There will be no dose-response relationship to UL performance in daily life. 
Hypothesis 1c: Concordance (i.e. paretic hand = dominant hand) will not modify UL 
performance in daily life.  
Aim 2: Determine the natural trajectory of self-perceived barriers and psychosocial factors 
related to UL performance over the first 6 months following a stroke.  Using a longitudinal 
inception cohort, a health behaviors survey will quantify psychosocial factors and self-perceived 
barriers to UL performance at 2, 4, 6, 8, 12, 16, 20, and 24 weeks post-stroke.  
Hypothesis 2a: Belief, confidence, and motivation will be high immediately after stroke and 
persist over 24 weeks. 
Hypothesis 2b: The total number of perceived barriers to UL use will be the highest immediately 
after stroke and decline over 24 weeks. 
Hypothesis 2c: Depressive symptomatology and cognitive impairment will have a negative 
association with belief, confidence, and motivation to improve UL performance.    
Aim 3: Characterize the relationship between psychosocial factors, self-perceived barriers, 
and UL performance over the first 12 weeks post-stroke. Using the same longitudinal cohort, 
wrist-worn accelerometers will quantify UL performance at 2,4,6,8, and 12 weeks post-stroke. 
Hypothesis 3a: UL performance will significantly increase over the first 12 weeks post-stroke.  
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Hypothesis 3b: Individual belief, confidence, and motivation to improve UL performance will 
significantly moderate UL performance. 
Hypothesis 3c: A greater number of self-perceived barriers will result in less UL use in daily life 
(negative association). 
 Implications for rehabilitation 
Together, these aims will be the first to examine the translation of UL capacity gains to daily life 
post-stroke, characterize how belief, confidence, and motivation evolve over the first 6-months 
post-stroke, map the natural trajectory of UL performance early after stroke, and explore the 
potentially mediating role of these psychosocial factors on UL performance. The knowledge 
gained here will increase our overall understanding of how other factors beyond the motor 
system may influence UL performance outcomes. This will provide critical information for 
future UL interventions designed to improve individual outcomes after stroke. 
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2.1 Abstract 
Background: A common assumption is that changes in upper limb (UL) capacity, or what an 
individual is capable of doing, translate to improved UL performance in daily life, or what an 
individual actually does. This assumption should be explicitly tested for individuals with UL 
paresis post-stroke. Objective: To examine changes in UL performance after an intensive, 
individualized, progressive, task-specific UL intervention for individuals at least 6 months post-
stroke. Methods: Secondary analysis on 78 individuals with UL paresis who participated in a 
Phase II, single-blind, randomized parallel dose-response trial.  Participants were enrolled in a 
task-specific intervention for 8 weeks. Participants were randomized into 1 of 4 treatment groups 
with each group completing different amounts of UL movement practice. UL performance was 
assessed with bilateral, wrist-worn accelerometers once a week for 24 hours throughout the 
duration of the study. The six accelerometer variables were tested for change and the influence of 
potential modifiers using hierarchical linear modeling. Results: No changes in UL performance 
were found on any of the 6 accelerometer variables used to quantify UL performance. Neither 
changes in UL capacity nor the overall amount of movement practice influenced changes in UL 
performance. Stroke chronicity, baseline UL capacity, concordance, and ADL status significantly 
increased the baseline starting points but did not influence the rate of change (slopes) for 
participants. Conclusions: Improved motor capacity resulting from an intensive outpatient UL 
intervention does not appear to translate to increased UL performance outside the clinic. 
 
2.2 Introduction 
A large proportion of individuals post-stroke experience significant difficulty incorporating their 
paretic hand into daily activities and they often identify improved upper limb (UL) function as a 
30 
 
top rehabilitation priority.1-4  Despite the resources spent on stroke rehabilitation, individuals 
continue to experience ongoing barriers with performing activities at home and will ultimately 
discontinue 57% of their daily activities.5 Given the importance of both upper limbs in daily 
activity,6 decreased daily performance following stroke is likely influenced by UL paresis. 
Clinical interventions to address UL paresis are often aimed at improving UL capacity, which 
describes an individual’s ability to execute a task, or what a person is capable of doing, within 
the structured environment of a clinic or laboratory.7 A common assumption is that improvement 
in UL capacity directly translates to improved UL performance. Performance describes what 
individuals actually do in their current environment, outside of the clinic or laboratory.7  Recent 
research has emphasized the importance of measuring capacity and performance separately.8,9   
 
Protocol-based UL motor interventions can improve capacity after stroke.10-14  Less clear is 
whether gains made in UL capacity, measured with standardized assessments (e.g. Action 
Research Arm Test15 [ARAT] and Wolf Motor Function Test16), translate to improved UL 
performance, or use, in daily life.  Several studies have reported increased UL performance when 
measured via self-report,10,17-19 and individuals with larger improvements in UL capacity 
demonstrate a positive trend towards clinically significant changes in self-reported 
performance.10,17,19  Self-report measures, however, are subject to many report biases including 
cognitive deficits20,21 and social desirability.22  Self-report measures often rely on an individual’s 
ability to recall activities completed over a previous week, which may be of particular difficulty 
for individuals with stroke, given the high prevalence of cognitive impairment.23,24  Pilot studies 
that have used a more quantitative measure of UL performance, i.e. accelerometry, report little to 
no improvement in UL performance in daily life, despite gains in UL capacity.25-27  The growing 
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emphasis on efficient, evidence-based rehabilitation services demands an evaluation of the 
relationship between change in UL capacity and change in UL performance in post-stroke 
chronic UL paresis.   
 
In this analysis, we examine changes in performance in the community that resulted from an 
individualized, intensive, progressive, task-specific UL intervention. We explicitly test the 
assumption that increased UL capacity translates to increased UL performance using data from a 
recent clinical trial.14  Finally, we examine the effect of dose (i.e. amount) of task-specific 
movement practice on UL performance in daily life. 
2.3 Methods 
This paper is a secondary analysis from a Phase II, single-blind, randomized, parallel dose-
response trial (NCT 01146379).14  Individuals were recruited for this study via the Brain 
Recovery Core database and the Cognitive Rehabilitative Research Group at Washington 
University in St. Louis, MO.  Inclusion criteria were: 1) ischemic or hemorrhagic stroke as 
determined by a stroke neurologist and consistent with neuroimaging; 2) time since stroke ≥ 6 
months; 3) cognitive skills to actively participate, as indicated by scores of 0-1 on items 1b and 
1c of the National Institutes of Health Stroke Scale (NIHSS);28 4) unilateral UL weakness, as 
indicated by a score of 1-3 on item 5 (arm item) on the NIHSS; and 5) mild-to-moderate 
functional motor capacity of the paretic UL, as indicated by a score of 10-48 on the ARAT.15,29,30  
The lower limit of 10 on the ARAT meant that participants had at least some ability to open the 
hand, grasp and lift off the table at least 2-3 test items.  Exclusion criteria were: 1) participant 
unavailable for 2-month follow-up; 2) inability to follow-2-step commands; 3) psychiatric 
diagnoses; 4) current participation in other UL stroke treatments (e.g. Botox); 5) other 
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neurological diagnoses; 6) participants living further than one hour away and were unwilling to 
travel for assessment and treatment sessions; and 7) pregnancy.  The trial was approved by the 
Washington University Human Research Protection Office and all participants provided 
informed consent.   
 
Clinical trial details and primary outcomes have been reported.14  Briefly, the primary aim of the 
trial was to determine the range of doses of UL task-specific practice that produce the largest 
change in UL functional capacity in individuals with chronic UL paresis.  Participants were 
randomized into one of four groups.  Dose was quantified by the total number of repetitions 
achieved over the course of the intervention. The four dose groups were: 3200 (100 
repetitions/session; median = 13.6 hours of active practice), 6400 (200 repetitions/session; 20 
hours of active practice), 9600 (300 repetitions/session; 26.3 hours of active practice), and 
individualized maximum, respectively.  Participants completed four treatment sessions per week 
for 1-hour over eight weeks.  The individualized maximum group completed 300 repetitions per 
session and continued their enrollment past the 8 weeks until specific stopping criteria were met 
(32.8 hours of active practice).14  The >32 hours of active practice in the individualized 
maximum group is  likely equivalent to the total scheduled therapy time in the constraint induced 
movement therapy trials (≥ 65 hours),31 given that active practice is often 50% or less of 
scheduled time.32,33  At least once every two weeks throughout the length of enrollment, 
participants were asked questions related to UL performance at home (e.g. what new activities 
have you tried with your arm?) and new activities were identified and discussed to help facilitate 
increased UL performance at home.  The primary outcome for the trial was the ARAT, a valid 
and reliable measure of UL capacity.34-36 
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2.3.1 Performance Measures 
UL performance was measured with bilateral, wrist-worn accelerometers (w GT3X+, Actigraph, 
Pensacola, FL).  Accelerometers are a well-established, valid, and reliable instrument for 
quantifying UL performance in both non-disabled adults6,9 and individuals with stroke.9,25,37-40 
Accelerometers record accelerations along three axes in activity counts where 1 count = 
0.001664 g.  Data were sampled at 30 Hz and activity counts were binned into 1-second epochs 
for each axis using ActiLife 6 (Actigraph Corp., Pensacola, FL) software.  Activity counts across 
each axis were combined to create a single vector magnitude value (√x2+y2+z2) for each second.   
 
Each participant wore bilateral, wrist accelerometers once a week for 26 hours throughout the 
intervention, at the conclusion of the intervention, and at 2-months follow-up.  Using custom-
written software in MATLAB (Mathworks Inc., Natick, USA) the first two hours of each 
recording were removed because this included the time in therapy session plus transportation 
home afterwards.  Data from the remaining 24 hours at home were used for this analysis. The 
single day wearing period was chosen because previous research has shown this is an adequate 
representation of performance in non-employed adults6,40,41 and to ensure increased adherence to 
wearing the accelerometers multiple times over the course of the study.  Accelerometers are 
waterproof so participants could wear them for all activities, including bathing.  Accelerometers 
were worn during the night (sleeping) and those data are part of the 24 hours.  Accelerometers 
were returned the next treatment session and the data were downloaded using ActiLife 6 
software.   
 
Six variables were calculated from the data collected over the 24 hours at home, with each 
variable quantifying different, but related, aspects of UL movement. Upper limb movements 
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associated with walking were included in our calculations.  Previous work has established that 
walking does not influence the accelerometer ratio variables in individuals post-stroke.37  
Although inclusion of walking does not change the non-ratio variables for neurologically-intact 
adults,42 it is possible that the inclusion of walking could result in an overestimation of the non-
ratio variables for participants with stroke.  We first examined summary variables of UL 
performance with the use ratio (also called activity ratio) and hours of use. The use ratio is the 
hours of paretic limb use divided by the hours of non-paretic limb use and quantifies the 
contribution of the paretic limb relative to the non-paretic limb to an activity.6  Healthy, 
neurologically intact adults (54.3 ± 11.3 years of age, 53% female, and 84% right hand 
dominant, recruited to match the demographic characteristics of the trial participants)9 have a use 
ratio of 0.95 ± 0.06, indicating nearly equal amounts of UL movement during activities.6  A use 
ratio value close or equal to 1 indicates nearly equal durations of activity from both limbs while 
values less than 1 indicate greater non-paretic activity and values greater than 1 would indicate 
more paretic UL activity.6  The total hours of use is the total amount of time, in hours, the paretic 
limb was active, as measured by summing the seconds when the activity count was > 2, and is a 
broad measure of paretic limb activity over the recording period.6,9  Neurologically intact adults 
use their dominant UL 9.1 ± 1.9 hours and their non-dominant UL 8.6 ± 2.0 hours.6   
 
We then more closely examined, on a second-by-second basis, the contribution of both limbs to 
activity and the intensity of movement with the magnitude ratio and bilateral magnitude, 
respectively. The magnitude ratio is the natural log of the vector magnitude of the paretic UL 
divided by the vector magnitude of the non-paretic UL, and describes the contribution of both 
limbs to an activity for each second of data.43  A magnitude ratio value of 0 indicates both ULs 
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contributed equally to an activity.9,43  A negative magnitude ratio value indicates greater non-
paretic UL activity and positive values indicate greater paretic UL activity.9  Across 74 healthy, 
non-disabled adults, the median magnitude ratio value (median of all the seconds recorded 
during 24 hours) averages -0.1 (0.3), indicating that both ULs are used nearly the same amount 
during activity.9  The bilateral magnitude measures the intensity of UL activity by summing the 
vector magnitude of the paretic UL and the non-paretic UL.43  The bilateral magnitude 
distinguishes between high intensity and low intensity movements, for every second of data.  
Bilateral magnitude values of 0 indicate no movement and increasing values are indicative of 
more intense UL movement. A referent median value of 136.2 (36.6) has been established in 
non-disabled adults.9  Higher values are associated with activities requiring larger, faster 
movements, (e.g. placing boxes on an overhead shelf).43  A low bilateral magnitude value would 
indicate smaller, less intense movements such as chopping vegetables.44   
 
The final quantification of UL performance examined only the paretic limb performance using 
the median paretic acceleration magnitude and the acceleration variability.  The median paretic 
acceleration magnitude captures the individual’s median acceleration value over the entire 
recording period.45  The acceleration variability is the variance of the mean acceleration value 
over the recording period and explains the average distance of the paretic accelerations from the 
mean acceleration.45  A higher value for both the median acceleration magnitude and 
acceleration variability indicates more overall UL movement and greater variability of 
movement, respectively.  
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These variables can detect differences between participants with stroke9 and, with the exception 
of the bilateral magnitude, are responsive to change in UL function following a task-specific 
intervention in individuals with UL paresis post-stroke.45  While not responsive to change in UL 
function, the bilateral magnitude may be a valuable variable for quantifying the intensity of 
bilateral movement, which is of interest to rehabilitation professionals. 
2.3.2 Statistical Analysis       
All data were analyzed in R, an open source statistical computing program.  The primary 
analysis used hierarchical linear modeling (HLM), also referred to as linear mixed effects 
regression analysis,14,46 for all six accelerometer variables.  HLM is applied to longitudinal data 
and is an extension of a traditional regression analysis.46  In contrast to repeated measures 
ANOVA, HLM allows for modeling of individual intercepts and slopes over time in addition to 
modeling potential moderators of the intercepts and slopes.  HLM does not require the same 
number of assessments across participants and can account for missing data, therefore 
participants with varying assessment sessions can still be included in the analysis.46  Slopes for 
each variable were of primary interest for this analysis, as they quantify the amount of change in 
UL performance over the duration of the study.  Preliminary analyses indicated that nonlinear 
model components were not necessary.  The group level intercepts and slopes are derived from 
the individual intercepts and slopes for each variable.46  
 
We initially analyzed change in UL performance across the entire sample by testing growth 
curves for all six variables, with individual time trajectories nested within participants (Model 1).  
This model allowed us to estimate the intercept and slope for the entire sample. Next, we tested 
the relationship between change in UL capacity (i.e. ARAT score) and change in UL 
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performance with nested models.  Participants were stratified into two groups, those who 
improved ≥ 6 points on the ARAT and those who did not improve at least 6 points, as the 6 point 
value has been previously described as an estimate of the minimal clinically important difference 
for individuals with chronic stroke.35  These two groups (dummy coded) were added to Model 1 
and time was nested within each participant, with individual intercepts and slopes allowed to 
vary randomly.  We evaluated the potential influence of change in UL capacity on both the 
intercepts and slopes (via group x time interaction).  Nested models were compared using χ2 tests 
and the final, best fit model for change in UL capacity was identified (Model 2). Additionally, a 
new series of nested models were created to test for a potential dose effect on UL performance 
by adding treatment group (dummy coded), and a group by time interaction to Model 1, yielding 
a final model identified as Model 3.  Outliers were identified using Cook’s distance and when 
necessary, models were re-evaluated with outliers excluded.  Across all levels of analysis, no 
outliers significantly influenced the results. We verified the inferences reported from the models 
using bootstrapping procedures and no differences were found as a result of this procedure.  
Finally, we evaluated the potential modifiers of time post-stroke (months), baseline UL capacity 
(i.e. ARAT score), concordance (dominant side = affected side), and activities of daily living 
(ADL) status (i.e. requires assistance vs. independent) and their influence on change in UL 
performance over time for all six variables. Each modifier was added to Model 1 separately, and 
the effects of the modifier on the intercept (baseline) and the slope (interaction between modifier 
and time) were evaluated (Models 4-7).  Time post-stroke is widely assumed to be a predictor of 
UL performance, therefore we tested its influence on both initial baseline intercept and change 
over time (i.e. slope).  Baseline ARAT scores were grand mean centered across all participants.  
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Concordance and ADL status were tested because they have previously been shown to modify 
UL performance in daily life.44      
 
Visual representations of accelerometer data were examined using density plots which display 
second-by-second data for the magnitude ratio (x-axis) and bilateral magnitude (y-axis) over the 
entire recording period, at every assessment time point. Example density plots have been 
previously published for healthy, neurologically intact adults (Figure 1, Bailey et. al; 
Supplemental Figure 1, Doman et. al27; Figure 3, Hayward et. al47).  There are a few salient 
characteristics in healthy adults that should be considered when interpreting these density plots.  
First, in healthy adults, plots are symmetrical, indicating that both ULs are used similarly.  The 
bottom portion is wide, and rounded, indicating that the majority of UL movements in a 24 hour 
period are low intensity.  Additionally, the rounded edges or rims of the bowl-like structure 
represent movements when one limb is moving while the other is relatively still (e.g. holding a 
piece of paper with one hand while the other hand writes, holding a container with one hand and 
opening it with the other).  The color bar represents the overall frequency of movement.  Warmer 
colors (i.e. red and/or orange) represent more UL movement overall, and the small color bars on 
both sides of the density plot are specific to the frequency of unilateral non-paretic UL 
movement and unilateral paretic UL movement, respectively.  While specific UL movements are 
highly variable across individuals,43 the salient characteristics of these graphs are highly 
consistent across community-dwelling, neurologically-intact nondisabled adults.9  Six examples 
of individual patients from the baseline data of this same cohort can be seen in Figure 2 of Bailey 
et al. NNR 2015.  Examples of how individual density plots change over time in persons with 
stroke can be seen in Figure 4B of Hayward et al.47 and in Figure 1 in Doman et al.27 
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2.4 Results 
Seventy-eight of the 85 participants in the trial had available data for this analysis.  Of the seven 
excluded participants, four had accelerometer recording errors, two withdrew from the study 
prior to the intervention, and one did not consistently wear the accelerometers for > 6 hours at 
each assessment time point.  Table 1 presents the demographic characteristics of the 78 
participants and baseline values for the six accelerometer variables.  The 6400 repetition group 
had low concordance (i.e. fewer people reporting their dominant side was the affected side).14  
Individuals had mild to moderate levels of UL paresis at baseline and most of the participants 
were independent with basic activities of daily living. 
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Table 2.1 Participant demographics and baseline accelerometer intercepts by treatment group 
 
Total sample 
(n=78) 
3200 Group 
(n= 19) 
6400 Group 
(n=21) 
9600 Group 
(n=21) 
IMb 
(n=17) 
Age (years) 61.9 ± 10.5 59.4 ± 12.5 62.6 ± 8.5 60 ± 8.3 62.4 ± 13.1 
Gender 27 F, 51 M 6 F, 13 M 5 F, 16 M 10 F, 11 M 6 F, 11 M 
Race 
40 Caucasian 
36 Af American 
1 Asian 
1 Multi-race 
10 Caucasian 
9 Af American 
11 Caucasian 
10 Af American 
10 Caucasian 
9 Af American 
1 Asian 
1 Multi-race 
9 Caucasian 
8 Af American 
Type of stroke 
56 ischemic 
10 hemorrhagic 
12 unknown 
14 ischemic 16 ischemic 15 ischemic 11 ischemic 
Months post-stroke 12 (5, 221) 11 (6, 180) 13 (6, 221) 13 (5, 54) 12 (6, 144) 
Affected side 36 L, 42 R 8 L, 11 R 11 L, 10 R 11 L, 10 R 6 L, 11 R 
% Concordancea  51% 58% 33% 48% 71% 
% Independent with 
ADL 
79% 89% 71% 86% 71% 
% Completed ≥ 32 
treatment sessions 
81% 89% 76% 71% 88% 
Baseline ARATc 
score 
32.4 ± 11.2 34.1 ± 7.9 31.9 ± 13.1 32.1 ± 12.3 31.7 ± 11.2 
Post-intervention 
ARAT scored 
36.9 ± 12.9 39.1 ± 8.7 36.4 ± 14.5 35.6 ± 15.4 36.5 ± 13.4 
Post-intervention #2 
ARAT scoree 
35.9 ±  13 38 ± 9.4 34.4 ± 14.1 34 ± 15.2 37.1 ± 13.8 
Baseline Values      
Use Ratio 0.66 ± 0.23 0.67 ± 0.19 0.61 ± 0.19 0.67 ± 0.21 0.73 ± 0.33 
Hours of Use 4.73 ± 2.12 4.72 ± 2.42 4.09 ± 2.23 4.82 ± 1.45 5.4 ± 2.32 
Magnitude Ratio -3.04 ± 2.86 -2.81 ± 2.68 -3.52 ± 2.96 -2.99 ± 2.81 -2.78 ± 3.21 
Bilateral Magnitude 89.29 ± 27.45 86.91 ± 34.34 83.64 ± 25.45 94.76 ± 21.38 92.02 ± 28.78 
Median acceleration 15.53 ± 17.61 14.21 ± 15.38 11.67 ± 13.06 17.67 ± 19.59 19.38 ± 22.28 
Acceleration 
variability  45.56 ± 17.46 45.22 ± 15.86 41.04 ± 13.07 49.61 ± 20.49 46.27 ± 19.91 
Values reported as means ± SD or median (range) as determined by distribution of data  
a = Concordance = dominant side is paretic side; values here indicate the percentage of the sample who 
identified their dominant upper limb as the paretic upper limb 
b = Individualized Maximum 
c = Action Research Arm Test; scores range from 0-57 points with higher scores indicating more normal 
movement  
d= Assessment completed immediately after the final treatment session 
e= Assessment completed 2 months after conclusion of intervention 
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Overall, there was no change in UL performance across all 78 participants on any of the six 
accelerometer variables. The final model for 5 of the 6 variables included the linear effect of 
time which produced better fitting models for the use ratio (χ2= 15.08, df =3, p = 0.002), hours of 
paretic limb use (χ2= 15.45, df=3, p = 0.001),  the magnitude ratio (χ2= 15.08, df =3, p = 0.03), 
median acceleration (χ2= 10.84, df = 3, p = 0.01), and the acceleration variability (χ2= 12.24, 
df=3, p = 0.007).  For the sixth variable, the bilateral magnitude, the addition of a linear effect of 
time was not significant (χ2= 2.76, df =3, p = 0.43), indicating that time did not increase the 
predictive ability of the model and was not a significant predictor of change.  Time was still 
included in the final model to acquire a slope value for the bilateral magnitude and also test 
potential modifiers of the slope.  Rates of change, quantified as model slopes are reported in the 
top row of Table 2, in units of change per week. The slopes for each accelerometer variable were 
not significantly different from zero. 
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Table 2.2 Slopes ± SE for entire sample, by group, ARAT change score, and potential modifiers   
  
 
Slope values reported as rate of change per week over the duration of the study. 
a= Results from Model 1, slope is change over time (week) 
b= Results from Model 2, slope is interaction of time x ARAT change 
c = Results from Model 3, slope is interaction of time x treatment group 
d= Results from Model 4; Values reported for a 1-unit change in chronicity (i.e. 1 month), slope 
is the interaction of time x chronicity 
e= Results from Model 5; Values reported for 1-point increase in baseline ARAT score (e.g. for 
every one point increase in baseline ARAT score, the participant’s slope increased by 0.0001 on 
the use ratio), slope is interaction of time x baseline ARAT score  
f= Results from Model 6; Values reported for individuals who indicated their dominant UL was 
the paretic UL, slope is interaction of time x concordance 
g= Results from Model 7; Values reported for individuals who were independent with basic 
activities of daily living (ADL; e.g. bathing, dressing, toileting), slope is interaction of time x 
ADL independence
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To test the possibility that some changes in performance were masked in the entire sample, we 
grouped participants based on changes in UL capacity.  Seventy-five participants had available 
data for this portion of the analysis.  The three excluded cases withdrew from the study prior to 
the first assessment after treatment was initiated, and therefore did not have an ARAT change 
score. Individuals who had larger changes in UL capacity (ARAT change score  6 points, n= 
36) started better (higher baseline intercepts) for the use ratio (p < 0.001), hours of paretic limb 
use (p = .007), magnitude ratio (p < .001), median acceleration (p < .001), and acceleration 
variability (p < .001), as would be expected (values not shown).  Despite the better starting 
points, the interaction between ARAT change and time did not influence the rates of change 
between the two groups (p values > .05) and all slopes were still not significantly different from 
zero (Table 2, second row of data). 
 
The addition of treatment group, and the interaction between treatment group and time also did 
not change the results.  Figure 1 illustrates the lack of group effect on all six variables.  No 
significant intercept and slope differences existed between groups and results from general linear 
hypothesis tests indicated none of the group slopes were significantly different from zero for any 
of the six variables (all p-values > 0.05).  Results of the group effects are reported in the middle 
rows of Table 2.  Finally, we tested potential modifiers that have previously been shown to 
influence UL performance.44  Time post-stroke, baseline UL capacity, concordance, and ADL 
status influenced the starting points (i.e. better baseline intercepts) as expected, but did not 
influence change over time (model slopes calculated from time x modifier interaction, all p-
values > 0.05, slope values reported at the bottom of Table 2).  Specifically, time post-stroke 
significantly influenced the use ratio (p =0.04) and magnitude ratio (p= 0.03) intercepts, 
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respectively, but was not a significant modifier of the remaining four intercept values.  Baseline 
UL capacity and ADL status significantly influenced the intercepts of all six variables, and 
concordance significantly influenced the use ratio (p < .001), magnitude ratio (p= 0.01), median 
acceleration (p=0.04), and acceleration variability (p = 0.04) intercepts.  
 
 
Figure 2.1 UL performance over time for all six accelerometer variables by dose group.  Values 
are group means ± SE for each assessment.  Week 1 corresponds to the baseline assessment, and 
subsequent weeks correspond to the weekly assessment out to the immediate post-intervention 
assessment and follow-up assessment.  Participants in the individualized maximum (IM) group 
were allowed to continue beyond the 8-week enrollment period until specific stopping criteria 
were met, observed here by the presence of additional data points. 
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Figure 2 provides representative individual examples of the lack of change in UL daily 
performance.  Despite substantial changes in UL capacity, participants 1 (10 point ARAT 
change) and 2 (18 point ARAT change) show no change in performance from baseline to post-
intervention.  The pictures from these two participants are not distinctly different from 
participant 3 (3 point ARAT change).  Compared to healthy, neurologically intact adults, the 
density plots in Figure 2 are all asymmetrical, with mostly negative magnitude ratio values that 
indicate increased non-paretic UL activity.  An absence of warmer colors indicate less movement 
overall, with no change in the frequency of movement from baseline to post-intervention.  There 
is a noticeable peak in the center of participant 1’s density plot at week four (i.e. a higher 
bilateral magnitude value), indicating more intense movements, but this was not sustained by the 
post-intervention assessment. While some participants showed small fluctuations such as this 
one, no subjects showed sustained changes over time. 
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Figure 2.2 Density plots showing second-by-second data from three representative participants. 
Time points are from baseline (top), week four (middle), and post-intervention assessments 
(bottom).  The y-axis (Bilateral magnitude) represents the intensity of movement, with higher 
values indicating larger, more intense movements.  The x-axis (Magnitude ratio) represents the 
contribution of each limb to an activity, with 0 indicating equal UL contribution, negative values 
indicate more non-paretic UL movement and positive values indicate more paretic limb 
movement. The color scale shows overall frequency of UL movement, with warmer colors 
indicating more UL movement.  The small bars on each side of the plot indicate non-paretic 
(negative) and paretic (positive) unilateral movement.  Overall, participants had a moderate level 
of UL paresis at baseline (participant 1 = 38 points; participant 2 = 35 points, and participant 3 = 
36 points). Participants 1 and 2 demonstrated 10-point and 18-point changes in ARAT score, 
respectively.  Participant 3 increased 3 points on the ARAT.  Regardless of UL capacity changes, 
there was no evidence of sustained changes in performance.  
47 
 
2.5 Discussion 
We evaluated changes in UL performance in daily life resulting from a task-specific intervention 
using a quantitative measure of performance.  None of the 78 participants increased their UL 
performance in daily life, as measured by the six accelerometer variables.  Dividing the sample 
into groups based on changes in UL capacity or dividing the sample into groups based on amount 
of motor practice failed to produce changes in performance over time.  Additionally, despite 
having various effects on the initial intercepts, none of the modifiers influenced change over time 
(slopes).  Thus, UL task-specific training, designed to improve UL capacity in the clinic may be 
unable to improve UL performance in daily life. This is contrary to the long-standing clinical 
assumptions that improving UL capacity directly translates to improved UL performance in daily 
life.      
 
A key reason people are referred to motor rehabilitation services is to improve UL performance 
in daily life.  With the cost of stroke expected to exceed 2.2 trillion dollars by 2050,48 it is 
striking that not one person changed UL performance after this carefully delivered intervention.14  
These results are consistent with a few other studies that have begun to identify a discrepancy 
between changes observed in the rehabilitation clinic (i.e. capacity) and a failure to increase UL 
performance in daily life both for adults26,49  and children50 (but see51).  When changes seen in 
the clinic do not carry over to life at home, then it is time to reconsider what is being delivered in 
the clinic and how it might need to be changed.    
 
One argument against these striking results is that perhaps the accelerometers failed to capture 
change that really occurred.  There are numerous studies of UL interventions post-stroke that 
have reported a positive increase in UL performance in daily life when measured via self-
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report10,17-19 and for individuals earlier after stroke, the MAL and use ratio are correlated.38  Self-
perception of changes in UL performance is a valuable component of the rehabilitation process, 
but perhaps not the whole story.  We cannot completely rule out the possibility that other 
variables from the accelerometers would show changes.  In deciding on these 6 variables 
however, we did test a number of others that were not useful (e.g. highly variable across 
neurologically intact population).39,43  Our accelerometers were on the wrists, so we also cannot 
completely rule out the possibility that small, dexterous movements of the fingers improved and 
we did not capture this.  This second possibility is also unlikely, since pilot testing with 
accelerometers picked up most of the hand/finger movements,43,52 particularly the less efficient 
and uncoordinated movements of the paretic hand and fingers post-stroke.  
 
There are several possible reasons for these striking results.  First, this study included those with 
chronic (≥ 6 months) stroke when habits have likely already formed.  Perhaps changes in UL 
performance would be observed if task-specific training was delivered earlier after stroke.  
Second, changes in capacity may be insufficient or not enough to improve UL performance in 
daily life.  There may be a specific threshold for UL capacity that must be exceeded to drive 
changes in UL performance.53,54  Third, UL performance is not solely a function of UL capacity 
but dependent on other factors such as motivation, health behaviors, and environmental supports.  
It is likely that these results are a combination of all three proposed reasons.  Future studies could 
examine the timing of intervention to improve UL performance post-stroke, as some pilot studies 
have reported changes in both UL capacity and UL performance earlier after stroke.27,55  
Additional studies could explore other potential factors related to UL performance such as health 
behaviors and motivation, and explicitly test interventions that target these factors.  Indeed, the 
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36 participants who demonstrated improvements in capacity (i.e. ARAT change ≥ 6 points) may 
be ideal candidates for interventions targeting UL performance in daily life, given their ability to 
change at this stage of recovery.       
 
Several limitations influence the interpretation of these data.  First, wearing sensors on the upper 
limbs could potentially cause people to do more with their ULs in daily life.  Sensor data were 
collected weekly with more than 8 assessments.  Thus the novelty of wearing the devices likely 
wore off early.  If anything, we may have overestimated UL performance in daily life within the 
first few assessments.  Second, the sensor-based methodology quantifies movement but does not 
quantify specific activities or movement parameters (e.g. speed, efficiency, accuracy). It is 
possible that some participants made small improvements in these parameters that went 
unmeasured.  These changes, however, were not sufficient to change the involvement of the 
paretic limb either in total duration (use ratio) or on a second-by-second basis (magnitude ratio). 
2.5.1  Conclusions 
We found no evidence of improvement in UL performance in daily life in 78 people with long-
standing paresis post-stroke who completed an 8-week individualized, intensive, progressive, 
task-specific intervention.  Neither changes in UL capacity nor the overall dose (i.e. amount) of 
movement practice influenced changes in UL performance.  These results expose an emerging 
problem in stroke rehabilitation.  Rehabilitation services, and the providing clinicians, may be 
changing what people can do while they are in the rehabilitation clinic, but these benefits do not 
carry over to improved UL performance at home, when measured with wrist-worn 
accelerometers.  If a primary goal of rehabilitation is to improve performance in daily life for 
individuals post-stroke, then it is imperative that future research investigate this emerging issue. 
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3.1 Abstract  
Background and Purpose: The recovery patterns of upper limb (UL) impairment after stroke are 
well-documented. Factors such as belief that paretic UL improvement is possible, confidence, 
and motivation to use the paretic UL in everyday tasks are unexplored early after stroke. The 
purpose of this study was to characterize belief, confidence, and motivation to use the paretic UL 
in daily life, and self-perceived barriers to UL recovery over the first 24 weeks post-stroke. 
Methods: This was a longitudinal cohort study (n=30) with eight assessment sessions over 24 
weeks. Belief, confidence, and motivation to use the paretic UL and self-perceived barriers to 
UL recovery were quantified via survey and analyzed using descriptive statistics. Change in the 
number of self-perceived barriers between weeks 2 and 24 was tested using a paired samples t-
test. The relationship between UL capacity, depressive symptomatology, cognition and each 
psychosocial factor were examined using Spearman’s rank-order correlation analyses. Results: 
Belief, confidence, and motivation to use the paretic UL were high across the 24 weeks, with 
little variation. There was no difference between the average number of barriers from weeks 2 to 
24. There was no relationship between the clinical measures and belief, confidence, and 
motivation at week 2, 12, or 24. Discussion and Conclusions: Low levels of belief, confidence, 
and motivation may not emerge until much later in the recovery process. The lack of consistent 
correlation between psychosocial factors and clinical outcomes suggests belief, confidence, and 
motivation may not be as vulnerable to functional status early after stroke as previously thought. 
3.2 Introduction 
By 2050, direct and indirect stroke costs are expected to exceed $1 trillion dollars,1 creating an 
urgent need for streamlined medical and rehabilitation services to reduce stroke-related 
disability. The purpose of rehabilitation is to help improve performance in daily life. 
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Performance, defined by the International Classification of Functioning (ICF) as what a person 
actually does outside of the clinic or laboratory,2 is a complex construct and likely influenced by 
many factors. Following a stroke, the multitude of deficits commonly observed makes 
performance in daily life even more restricted. Upper limb (UL) performance, or use, in daily life 
is no exception. Until recently, it was assumed that improved UL performance was directly 
linked to improved UL capacity, or what someone is capable of doing inside the clinic or 
laboratory.2 This assumption is not supported by evidence.3-6  As a result, there exists an urgent 
need to explore other factors that may influence UL performance in daily life.  
 
Motor sequelae post-stroke, compared to psychological/emotional impairment, are well 
established and receive a considerable amount of attention from the research community.7-9 
Quantifying psychosocial factors (belief, confidence, and motivation) and self-perceived barriers 
to performance in daily life is an important step in understanding how these factors may 
influence UL performance early after stroke. Belief, confidence, and motivation are empirically 
derived factors from Social Cognitive Theory10,11 and Social Determination Theory,12-14 two 
common behavioral theories. An individual’s belief and confidence to perform specific tasks can 
influence activity selection and completion.15 Indeed, self-efficacy (belief, confidence, and 
motivation being key components of self-efficacy15) post-stroke mediates walking 
performance,16,17 and is positively associated with physical activity,18 balance and walking,17,19 
independence with activities of daily living,20,21 onset of post-stroke depression,22 and overall 
well-being.23 Confidence is often linked to recovery, where increased confidence is a marker of 
progress while low levels of confidence may restrict individuals from reaching full recovery 
58 
 
potential.24 Motivation has been identified as a potential target for improving rehabilitation 
outcomes.25-27 
 
Despite the influence of these factors on the above stroke outcomes, little is known about how 
individual belief, confidence and motivation to use the paretic UL in daily life, and self-
perceived barriers to UL recovery evolve over the first 6 months following a stroke. Knowledge 
of psychosocial factors specific to UL recovery and use in daily life comes from cross-sectional 
studies of chronic (> 6 months) stroke survivors.28-30 While valuable, these data may differ from 
early stroke recovery, especially in the presence of acute psychological distress that is common 
after sudden health events such as stroke.31 Indeed, the rapid motor and functional changes 
frequently observed early after stroke may influence individual belief, confidence, and 
motivation to use the paretic UL in daily life differently than in the chronic phase, when the 
magnitude of change is often smaller. Understanding how these factors might change over the 
first 6 months post-stroke provides critical information for future performance-based UL 
interventions. Additionally, understanding how self-perceived barriers to UL recovery evolve 
over the first 6 months may also identify therapy targets to help improve overall UL use in the 
free-living environment. 
 
The purpose of this study was to characterize individual belief, confidence, and motivation to use 
the paretic UL in daily life over the first 24 weeks, or 6 months, post-stroke. A secondary 
purpose was to quantify self-perceived barriers to UL recovery over the same period. As 
rehabilitation research continues to emphasize performance in daily life, understanding how 
factors beyond the motor system evolve will provide critical insights into the sequelae of 
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psychosocial factors post-stroke. These data are necessary for the design of future trials that aim 
to increase performance in daily life. While this report examines these issues in UL performance, 
the results are important for all domains of stroke rehabilitation. 
3.3 Methods 
This was a longitudinal, prospective, inception cohort study. Participants were recruited from a 
large, urban hospital via the Stroke Patient Access Core at Barnes Jewish Hospital. Participants 
were enrolled within 2 weeks of a first-ever stroke, with residual UL paresis. Specifically, 
participants were included if the following criteria were met: 1) within two weeks of a first-ever 
ischemic or hemorrhagic stroke, confirmed with neuroimaging; 2) presence of UL motor deficits 
within the first 24-48 hours post-stroke, as indicated by a National Institutes of Health Stroke 
Scale (NIHSS) Arm Item score of 1-4 or documented manual muscle test grade of <5 anywhere 
on the paretic UL; 3) able to follow a 2-step command, as measured by a NIHSS Command Item 
score of zero; and 4) anticipated return to independent living, as indicated by the acute stroke 
team. Participants were excluded from the study if any of the following criteria were met: 1) 
history of previous stroke, neurological condition, or psychiatric diagnoses; 2) presence of other 
comorbid conditions that may limit recovery (e.g. end-stage renal disease or stage IV cancer); 3) 
lives more than 90 minutes from study location; and 4) currently pregnant by self-report. All 
participants provided written, informed consent and the study was approved by The Human 
Research Protection Office at Washington University in St. Louis, MO.  
 
Participants underwent eight assessment sessions over the first 24 weeks, or 6 months, post-
stroke. A battery of assessments was administered by the research coordinator at 2, 4, 6, 8, 12, 
16, 20, and 24 weeks with each session lasting approximately 30-60 minutes. Assessment 
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sessions were completed every 2-weeks in the beginning to capture the anticipated large, rapid 
improvements in UL capacity and then transitioned to every month as recovery slowed. Due to 
the observational design, the amount and type of rehabilitation services were not controlled for in 
this study. Instead, participants received rehabilitation services in accordance with the medical 
team’s recommendations. The study assessments were administered in the research lab, inpatient 
rehabilitation hospitals, skilled nursing facilities, or the participants’ homes, depending on 
location and travel abilities.  
3.3.1 Study assessments 
Individual belief, confidence, and motivation to use the paretic UL in everyday tasks and self-
perceived barriers to UL recovery were quantified via survey. The survey was developed using 
focus group data from a large cohort of stroke survivors in Australia and modified for use in the 
United States.28,29 Using focus group data ensured the survey items quantified salient survivor 
concerns as opposed to researchers speculating what issues were most important to survivors. 
The modified survey consists of four sections: I. Participant estimation of total amount of time 
spent improving UL function, II. Self-perceived barriers to paretic UL recovery (e.g. not enough 
movement to work with, lack of support from health professionals), III. Statements about 
individual belief (I believe further improvement of my [paretic] arm and hand is possible), 
confidence (I feel confident to do what I need to do to use my [paretic] arm and hand in everyday 
tasks), and motivation (I want to be able to use my [paretic] arm and hand more in everyday 
tasks). Participants respond to the statements in section III using a 4-point Likert scale 
(4=strongly agree, 3=slightly agree, 2=slightly disagree, and 1=strongly disagree). The fourth 
section (IV), not included in this report, measured participant readiness to change/use the paretic 
UL in daily activities.   
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3.3.2 Additional assessments  
Upper limb motor capacity was assessed using the Action Research Arm Test (ARAT).32 The 
ARAT is a valid and reliable measure of UL capacity for adults with stroke.33-35 The ARAT is a 
19-item assessment with four subscales: grasp, grip, pinch, and gross motor. Scores for the 
individual items range from 0-3, where 0 = cannot complete, 1= performed partially, 2= task 
completed but with abnormal movement, and 3= performed normally. Individual items are 
summed and final scores range between 0-57, with higher values indicating better UL function. 
 
Cognitive function was screened using the Montreal Cognitive Assessment (MoCA).36 The 
MoCA is a valid and reliable cognitive screening tool and is more sensitive in detecting mild 
cognitive impairment compared to the Mini Mental Status Exam.37-39 The MoCA tests for 
cognitive impairment across eight domains (visuospatial/executive functioning, naming, 
memory, attention, language, abstraction, delayed recall, and orientation), and scores range from 
0-30, with scores < 26 indicating cognitive impairment.36 Depressive symptomatology was 
examined using the Centers for Epidemiological Studies Depression Scale (CES-D)40 that has 
been validated for use in adults with stroke.41,42 Scores for the CES-D range from 0-60, with 
higher scores indicative of greater depressive symptomatology. A simple demographics 
questionnaire collected pertinent demographic information. Lastly, participants self-reported if 
they were receiving rehabilitation, the setting (e.g. inpatient rehabilitation, outpatient), 
disciplines (e.g. physical therapy, occupational therapy, speech language pathology), and 
frequency per week. 
 
Both the psychosocial survey and the CES-D require standardized scales, wherein the 
participants choose the appropriate response to each item of the test. For both assessments, the 
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respective scales were printed in large font, laminated, and placed in front of the participant. In 
effort to reduce information burden, the assessor would read each statement aloud, repeating 
upon request, and the participant would indicate either verbally or by pointing, their answer to 
each item. This was repeated for section III of the psychosocial survey and for every item on the 
CES-D. Reading each item to the participant eliminated the need for reading glasses that were 
often missing early after stroke and reduced overall fatigue. Participants reported satisfaction 
with this approach.  
3.3.3 Statistical Analysis 
All analyses were completed in R (version 3.3.2),43 an open source statistical computing 
program. Descriptive statistics were calculated for belief, confidence, and motivation at each 
assessment week. The total number of self-perceived barriers was the sum of the total number of 
barriers identified. The average number of self-perceived barriers per participant and the 
standard error were calculated for each assessment week. The difference in the total number of 
self-perceived barriers at weeks 2 and 24 was tested using a paired samples t-test.   
 
The relationship between the psychosocial factors (i.e. belief, confidence, and motivation), UL 
capacity (ARAT), depressive symptomatology (CES-D), and cognitive function (MoCA) were 
analyzed using Spearman rank-order correlation analyses.  Correlation analyses were completed 
at weeks 2, 12, and 24, respectively, and Holm’s method was applied to adjust for multiple 
comparisons. The significance level was established at α < 0.05 for all analyses. 
3.4 Results 
Thirty of the thirty-two enrolled participants had available data for this analysis. The two 
excluded participants were a result of a screen failure and withdrawal prior to the first 
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assessment session. Table 1 reports key participant demographic information. Eight participants 
dropped out of the study between weeks 2 and 24, due to self-selected withdrawal (n=3), second 
stroke (n=1), fatal cancer diagnosis (n=1), fall resulting in fractured UL (n=1), and decline in 
medical status (n=2). Nearly all participants received rehabilitation services immediately after 
their stroke (week 2) and services tapered over the study duration. All participants were 
independent with basic activities of daily living prior to their stroke and 37% of the sample 
reported their dominant limb was their paretic limb (i.e. concordance).  
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Table 3.1 Participant demographics 
 Total sample (n=30) 
Age (years) 68.4 ± 9.9 
Gender 12 F, 18 M 
Race 
23 Caucasian 
6 African American 
1 Asian/ Pacific Islander 
Stroke type 30 ischemic  
Stroke location 
17 cortical 
11 subcortical 
1 cortical & subcortical 
1 posterior circulation/cerebellar 
Affected side 20 L, 10 R 
Concordance, n (%)a 11 (37%) 
Prior working status 
21 not working 
9 working at least part-time 
% Independent with ADL prior to stroke 100% 
% Living alone prior to stroke 20% 
Self-reported comorbidities, median (range)b 2 (0,4) 
% Receiving rehabilitation services 
Week 2 (n=30) 
Week 4 (n=27) 
Week 6 (n=26) 
Week 8 (n=24) 
Week 12 (n=22) 
Week 16 (n= 23) 
Week 20 (n=20) 
Week 24 (n=22) 
 
90% 
78% 
69% 
71% 
55% 
48% 
35% 
23% 
% Admitted to rehabilitation hospital at week 2  83% 
Days post-stroke assessments administered 
Week 2  
Week 4  
Week 6  
Week 8 
Week 12  
Week 16 
Week 20 
Week 24 
 
13.4 ± 2.9 
27.3 ± 1.9 
41.6 ± 3.1 
56.3 ± 2.6 
84.7 ± 2.9 
113 ± 4.1 
140 ± 2.1 
169 ± 2.7  
Week 2 Values  
ARATc 22.9 ± 21.4 
MoCA score, median (range)d 21 (11, 29) 
CES-D score, median (range)e 7 (0, 44) 
Values are mean ± SD unless otherwise indicated 
a Dominant limb=paretic limb 
b Median number of comorbidities per participant 
c ARAT=Action Research Arm Test, scores range from 0-57, higher values=better function 
d MoCA= Montreal Cognitive Assessment, scored 0-30, lower scores may also reflect aphasia or fatigue  
e CES-D=Centers for Epidemiological Studies-Depression Scale; scored 0-60 with higher scores 
indicating greater depressive symptomatology 
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Across the 24-week study duration, there were high levels of belief, confidence, and motivation 
across the sample (median value=4, strongly agree). Figure 1 presents the percentage of 
responses using the Likert scale for each assessment session. Across all eight assessment 
sessions, the large majority of participants strongly agreed that further improvement of their 
paretic UL was possible (belief), they were confident to use their paretic UL, and were motivated 
to use their paretic UL in daily life. As seen in Figure 1, in the event individuals did not strongly 
agree to each question, they often slightly agreed, and rarely disagreed to any of the questions, at 
any point in time. 
 
 
Figure 3.1 Percent of the sample who responded they strongly agreed, slightly agreed, slightly 
disagreed, or strongly disagreed to the individual statements of belief, confidence, and 
motivation. The large majority of participants indicated they strongly agreed further 
improvement of their paretic UL was possible (belief), and were confident and motivated to use 
the paretic UL in everyday tasks at every assessment session.  
 
 
The average number of self-perceived barriers to UL recovery per participant slightly varied 
between week 2 (3.4 ± 2.7), week 12 (1.9 ± 2.2), and week 24 (2.2 ± 3.2). Figure 2 displays the 
average number of self-perceived barriers per participant across all eight assessment sessions. 
There was not a significant difference in the total number of self-perceived barriers between 
weeks 2 and 24 (t=1.42, 95% CI= [-0.43, 2.23]) for the 22 participants who had available data at 
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both time points. Table 2 lists the 13 possible barriers and the number of participants who 
answered “yes” to that barrier at weeks 2, 12, and 24. Overall, the top barrier varied across the 
three assessment periods, with nearly all participants indicating limited UL movement as a 
barrier at week 2, but this did not persist over time. The most common barrier at weeks 12 and 
24 was feeling they could not do things correctly when attempting to use the paretic UL in daily 
life. 
 
Figure 3.2 Average number of self-perceived barriers to UL recovery per participant across the 
eight assessment sessions. Values are mean  SE. 
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Table 3.2 Self-perceived barriers to recovery (value represents number of participants who 
indicated the listed barrier limited recovery) 
 
 
Week 2 
(n=30) 
Week 12 
(n=22) 
Week 24 
(n=22) 
Not enough movement to work with 22 5 3 
Too many other things to deal with 14 1 6 
Feeling I can’t do things correctly 14 6 7 
Lack of information 9 3 2 
Other, more worrisome health problems 8 6 5 
Too tired 8 5 5 
Feeling what I do doesn’t help 7 3 5 
Too many other responsibilities 5 2 5 
Lack of money 4 5 4 
Difficulty getting out of the house 3 5 4 
Lack of support from family/friends 3 0 1 
Lack of support from health professionals 2 0 1 
Not interested 2 0 1 
 
  
There were no consistent relationships between belief, confidence, and motivation and UL 
capacity, depressive symptomatology, and cognitive function. Table 3 presents the correlation 
coefficients at weeks 2, 12, and 24. After correcting for multiple comparisons using Holm’s 
method, no correlations were significant at any time point. 
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Table 3.3 Correlation coefficients at weeks 2 (n=30), 12 (n=22), and 24 (n=21) 
 
 ARATa CES-Db MoCAc 
 Week Week Week 
 2 12 24 2 12 24 2 12 24 
Belief 0.07 -0.03 -0.01 -0.34 -0.29 0.13 -0.04 -0.07 -0.25 
Confidence -0.08 -0.17 0.58 -0.43 -0.04 0.18 0.12 -0.20 -0.05 
Motivation -0.34 -0.41 -0.09 0.03 0.19 0.54 -0.38 -0.18 -0.16 
 
a ARAT= Action Research Arm Test, scores range 0-57, with higher scores indicating better UL 
function  
b CES-D= Centers for Epidemiological Studies Depression Scale, scores range 0-60, with higher 
scores indicating greater depressive symptomatology  
c MoCA = Montreal Cognitive Assessment, scores range 0-30, with higher scores indicating 
better cognitive function 
 
3.5 Discussion 
This was the first study to quantify individual belief that further improvement of the paretic UL 
was possible, and confidence and motivation to use the paretic UL in daily life over the first 24 
weeks post-stroke. Prior to this study, our limited knowledge of these factors came from cross-
sectional data in chronic stroke cohorts.28-30 Quantifying these psychosocial factors early, over 
multiple assessment sessions, captures their dynamic nature which provides a more robust 
understanding of the recovery process. The key finding from this study was the high, unwavering 
levels of belief, confidence, and motivation over the first 24 weeks post-stroke. In the event 
participants did not strongly agree to each question, they often slightly agreed, and rarely 
disagreed.   
 
Belief, confidence, and motivation to act in a given scenario influence actual behavior and 
activity selection.10,15,44 Thus, characterizing these factors over the first 24 weeks post-stroke, a 
critical time for recovery, provides novel insight into how these factors may evolve as 
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individuals progress, plateau, or decline early after stroke. There is a growing emphasis on 
motivation and other psychosocial/behavioral factors as possible targets for improving UL and 
stroke outcomes.25,26 Our data suggest that early after stroke, improving these psychosocial 
factors may not be as critical as previously thought. Instead, developing novel interventions with 
behavioral components (e.g. feedback, incentives) that exploit these high levels and promote UL 
use may help increase overall UL performance in daily life. 
 
These data may be applicable to other stroke rehabilitation areas such as walking and balance. 
Limited longitudinal data exist to explain how belief, confidence, and motivation for balance or 
walking may change early after stroke. It is reasonable to assume that confidence, for example, 
may strongly influence walking behavior after stroke given the fear of falling or other safety 
concerns that can have significant repercussions. There are few, if any, substantial risks to using 
the paretic UL in daily life. The high levels of individual belief, confidence, and motivation 
reported here may be partially influenced by the relatively low risks of using the paretic UL in 
everyday tasks. Because stroke often results in multiple, complex impairments (e.g. cognitive, 
communication, and motor), future work will want to explore belief, confidence, and motivation 
for other stroke impairments both individually and as a group over time. Belief, confidence, and 
motivation to use the paretic UL may lessen when contextualized with other impairments (i.e. 
motivation to use the paretic UL may be reduced by heightened motivation to improve 
communication or resume walking).     
 
Results from the correlation analyses show belief, confidence, and motivation are not associated 
with UL capacity, depressive symptomatology, and cognition in this sample. This is important 
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for future UL performance research. The common clinical domains tested here (capacity, 
depressive symptomatology, and cognition) appear less influential with psychosocial factors 
compared to other aspects of stroke recovery (e.g. walking, self-management). Belief, 
confidence, and motivation may be influenced by other, less common factors such as self-
regulation,10,14 perceived competence and control,14,44 and environmental/social factors.10 Future 
research may want to explore these factors as they relate to belief, confidence, and motivation. 
 
Several limitations influence the interpretation of these data.  The small sample size limits the 
generalizability of these results, and a larger study is currently underway to validate these 
findings. Nearly all participants in this sample improved their UL capacity over the study 
duration, which may have contributed to the high levels of belief, confidence, and motivation. As 
expected in the 24 weeks following a stroke, some participants withdrew from the study prior to 
completing all eight assessment sessions. It is possible, although unlikely, these participants 
could have reported low levels of belief, confidence, and motivation. Additionally, and most 
importantly, belief, confidence, and motivation are complex constructs. In this study, we did not 
query every possible dimension of these constructs (e.g. intrinsic vs. extrinsic motivation). 
Future work may want to explore each construct in greater detail to provide a more robust 
understanding of what components may be most affected in the recovery process or utilize 
qualitative methods to develop a deeper understanding of these constructs in this population. 
Currently, there is a lack of UL-specific assessments to quantify these factors (e.g. no UL 
specific self-efficacy scale). It may be worthwhile to develop an UL-specific self-efficacy scale 
for future work given that self-efficacy is task-specific and varies across circumstances.45,46  
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3.5.1 Conclusion 
Just as there are recovery and disability trajectories,47,48 there is also a natural trajectory of 
psychosocial factors that can change as a result of biological, personal, and environmental 
factors. The initial 24 weeks after stroke often includes rapid, notable improvement in physical 
function, transitions between medical facilities and home, and attempts to return to pre-stroke 
routines and life roles. An individual’s belief, confidence, and motivation to use the paretic UL 
in everyday tasks may be less vulnerable early after stroke to their changing functional status and 
environment than previously thought. As a result, future UL interventions may consider focusing 
more on reducing self-perceived barriers to UL recovery and other novel techniques that 
leverage high levels of confidence and motivation to increase UL use in everyday tasks. 
Devoting time and resources to characterizing these psychosocial factors for other stroke related 
deficits is a worthwhile endeavor given the dynamic nature of belief, confidence, and motivation. 
This will ultimately lead to more robust, multi-dimensional interventions that may help improve 
outcomes post-stroke. 
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Chapter 4: Upper limb performance in daily 
life improves over the first 12 weeks post-
stroke 
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4.1 Abstract 
Background: Upper limb (UL) performance, or use, in daily life is complex and likely influenced 
by many factors. While the recovery trajectory of UL impairment post-stroke is well 
documented, little is known about the natural trajectory of sensor measured UL performance in 
daily life early after stroke and the potential moderating role of psychosocial factors.        
Objective: To examine the natural trajectory of UL performance within the first 12 weeks post-
stroke and characterize the potential moderating role of belief, confidence, and motivation on UL 
performance. Methods: This was a longitudinal, prospective cohort study quantifying UL 
performance and related psychosocial factors early after stroke. UL performance was quantified 
via bilateral, wrist-worn accelerometers over five assessment sessions for 24-hours. Individual 
belief, confidence, and motivation to use the paretic UL, and self-perceived barriers to UL 
recovery were quantified via survey. Change in four accelerometer variables and the moderating 
role of psychosocial factors was tested using hierarchical linear modeling. The relationship 
between self-perceived barriers and UL performance was tested via Spearman rank-order 
correlation analysis. Results: UL performance improved over the first 12 weeks after stroke. 
Belief, confidence, and motivation did not moderate UL performance over time. There was a 
negative relationship between UL performance and self-perceived barriers to UL recovery at 
week 2, which declined over time. Conclusions: Sensor measured UL performance can improve 
early after stroke. Early after stroke, rehabilitation interventions may not need to directly target 
belief, confidence, and motivation but may instead focus on reducing self-perceived barriers to 
UL recovery. 
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4.2 Introduction 
Rehabilitation services aim to reduce the long-term effects of post-stroke disability. Motor 
system impairments are one of the top reasons individuals are referred for rehabilitation 
services.1-3 Indeed, nearly 80% of individuals will experience some degree of upper limb (UL) 
paresis after a stroke.4 At 6 months, 65% of individuals will have difficulty incorporating their 
paretic UL into daily activities.5,6 Improving UL function is a top priority for many stroke 
survivors.7-9 As a result, researchers have invested significant time and money establishing 
several efficacious, protocol-based UL interventions both early10-13 and later14,15 after-stroke. 
These interventions are primarily designed to improve UL capacity. Capacity, quantified via 
standardized assessments in the rehabilitation clinic or laboratory, refers to what a person is 
capable of doing.16 It is often assumed in-clinic improvements in UL capacity directly translate 
to increased UL performance, or use, in daily life. Performance is defined by the International 
Classification of Functioning (ICF) Framework as what a person actually does outside of the 
clinic or laboratory.16 Recent research, however, does not support this assumption when 
performance is directly quantified via sensors (e.g. accelerometry).17-20  Instead, this emerging 
body of research posits that while UL capacity and UL performance appear similar, they are 
distinctly different constructs. 
 
The paucity of studies examining change in UL performance over the first 12 weeks after 
stroke,17,21 when majority of UL motor recovery occurs,22,23 is problematic. Understanding how 
UL performance changes during this critical period of motor recovery will provide important 
insights into the unique trajectory of real-world UL use after stroke. Preliminary data suggests 
some (n=2) individuals can improve UL performance early after stroke.21 Compared to the 
chronic phase (≥ 6 months), UL performance may increase over the first 12 weeks due to a 
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combination of factors unique to the early weeks post stroke: improvement in UL capacity, 
rehabilitation services, and less likelihood of learned non-use.24 These early facilitating factors 
likely serve as barriers in the chronic phase of UL recovery.20 Additionally, psychosocial factors 
and self-perceived barriers to UL recovery may influence UL performance in daily life early 
after stroke but have yet to be explored.  
 
Recent work suggests a more robust philosophy, including the substantial role of individual 
agency (i.e. an active role through biology, belief, and self-regulatory systems),25 in explaining 
the disparity between UL capacity and performance post-stroke.17,18 Psychosocial factors, such 
as belief, confidence, and motivation may underscore improved UL performance in daily life. 
Belief in one’s ability to succeed in a task, despite setbacks or challenges, can profoundly 
influence the types of activities people choose to perform.26 Both belief and confidence in one’s 
prospective ability to complete a task are key components of self-efficacy.27 Additionally, 
motivation is a key psychosocial factor for motor learning28 and behavior change29 and may 
potentially moderate real world UL performance as well. Recent work reports high levels of 
individual belief, confidence, and motivation early after stroke (Chapter 3). An important next 
step is to explore the potential moderating role of these psychosocial factors on UL performance 
early after stroke.  
 
Thus, the purpose of this study was to examine the natural trajectory of UL performance within 
the first 12 weeks post-stroke, when the majority of motor recovery and rehabilitation services 
occur. A secondary purpose was to characterize the relationship between UL performance and 
psychosocial factors related to UL performance. We specifically focused on individual belief that 
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further UL improvement is possible, and individual confidence and motivation to use the paretic 
UL in daily life. A third, exploratory purpose was to examine the relationship between total self-
perceived barriers to UL recovery and UL performance. 
4.3 Methods 
This was a longitudinal, prospective cohort study tracking UL performance and related measures 
over time. Potential participants admitted to a large, urban hospital were recruited via the Stroke 
Patient Access Center at Washington University. First-ever stroke survivors with residual UL 
paresis were enrolled within two weeks of their stroke. Participants were included in the study if 
the following criteria were met: 1) within two weeks of a first-ever ischemic or hemorrhagic 
stroke, confirmed with neuroimaging; 2) presence of UL motor deficits within the first 24-48 
hours post-stroke, as indicated by a National Institutes of Health Stroke Scale (NIHSS) Arm Item 
score of 1-4 or documented manual muscle test grade of <5 anywhere on the paretic UL; 3) able 
to follow a 2-step command, as measured by a NIHSS Command Item score of zero; and 4) 
anticipated return to independent living, as indicated by the acute stroke team. Participants were 
excluded from the study if any of the following criteria were met: 1) history of previous stroke, 
neurological condition, or psychiatric diagnoses; 2) presence of other comorbid conditions that 
may limit recovery (e.g. end-stage renal disease or stage IV cancer); 3) lives more than 90 
minutes from study location; and 4) currently pregnant by self-report. The Human Research 
Protection Office at Washington University in St. Louis, MO approved this study and all 
participants provided written informed consent.  
 
Study participants completed five assessment sessions over the first 12 weeks post-stroke. The 
assessment battery was administered at 2, 4, 6, 8, and 12 weeks, with each assessment session 
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lasting 30-60 minutes. The study coordinator (first author) administered assessments. All study 
participants, to varying degrees, received rehabilitation services during this 12-week period. We 
did not control for the amount or type of rehabilitation services delivered to each participant in 
this observational study. Instead, each participant received therapy services in accordance with 
their overall plan of care established by the medical team. Assessments were administered in 
either the research lab, participants’ homes, inpatient hospital wards, or other healthcare facilities 
depending on travel abilities.  
4.3.1 Study assessments 
Upper limb performance in daily life was quantified via bilateral, wrist-worn accelerometers 
(Actigraph Link, Pensacola, FL). Accelerometry is a valid and reliable measure of UL 
performance in both healthy adults30,31 and adults with stroke.32-35  Briefly, accelerometers record 
accelerations along three axes in activity counts where 1 count = 0.001664g. Data are sampled at 
30 Hz, band-pass filtered between frequencies of 0.25 and 2.5 Hz, and down sampled into 1-
second epochs (i.e. activity counts) for each axis using ActiLife 6 software (Actigraph Corp., 
Pensacola, FL). Activity counts are combined across the three axes to create a single value, a 
vector magnitude (√x2+y2+z2), for each second of data.  
 
Participants wore the accelerometers for 24-hours at each assessment time point. The 24-hour 
wearing period has previously shown to accurately reflect a typical day in adults with stroke (i.e. 
no difference between weekdays and weekends) and has high adherence rates.30,36,37 Participants 
were encouraged to wear the accelerometers at all times, including walking and bathing. Similar 
to previous work,30,31,34,35 accelerometry data were uploaded and processed using custom written 
software in MATLAB (Mathworks, Inc.). A threshold filter removed vector magnitude values < 
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2, which has been previously shown to significantly reduce variability and improve reliability of 
the accelerometer data.33 Four accelerometry-derived variables were included in this analysis: 
hours of paretic UL use, use ratio, magnitude ratio, and bilateral magnitude. These 
accelerometer-derived variables quantify somewhat different aspects of UL performance in daily 
life. Two variables, hours of paretic UL use and the use ratio (or activity ratio), quantify total 
duration of movement while the magnitude ratio and bilateral magnitude are second-by-second 
variables. 
 
Total hours of paretic UL use is the total time, in hours, the paretic UL was active over the 24-
hour recording period, as measured by summing the seconds when the activity count was ≥ 2.30 
On average, healthy, community-dwelling adults use their dominant UL 9.1  1.9 hours/day and 
their nondominant UL 8.6  2.0 hours/day.30 The total hours of paretic UL use are then divided 
by the total hours of nonparetic UL use to derive a use ratio.30,38  A use ratio value of 1 would 
indicate both limbs are active the same amount of time while a value of 0.5 would indicate the 
paretic UL was active 50% of the time the nonparetic UL was active. A referent value of 0.95  
0.06 has been previously established in healthy, community-dwelling adults.30 The magnitude 
ratio quantifies the contribution of each limb to an activity, for every second of data. The 
magnitude ratio value is the natural log of the paretic UL vector magnitude divided by the vector 
magnitude of the nonparetic UL.31,34 A magnitude ratio value of zero indicates equal contribution 
of both limbs to an activity. Negative magnitude ratio values represent greater use of the 
nonparetic UL while positive numbers represent greater paretic UL use. Previous work has 
established a median referent value of -0.1(IQR 0.3) in healthy adults.31,34 Lastly, the bilateral 
magnitude value is the sum of the vector magnitudes of the paretic and nonparetic UL, 
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respectively.31,34 The bilateral magnitude is a measure of the intensity of movement, with higher 
numbers reflecting greater intensity. Healthy adults have a median referent bilateral magnitude 
value of 136.2 (IQR 36.6).31,34 The hours of paretic UL use, use ratio, and magnitude ratio are all 
responsive to change in UL function.39 While not previously shown to be responsive to change, 
the bilateral magnitude represents intensity of movement, which may change during the early 
time period just after stroke. 
 
Individual belief, confidence, and motivation to use the paretic UL was queried using a modified 
version of a survey developed from focus group data.7,8 The full details of the survey have been 
previously reported (Chapter 3).8 Here, two of the four sections were used: Sections II and III. 
Section II quantifies self-perceived barriers to UL recovery (e.g. “not enough movement to work 
with” or “not interested”). Section III includes individual statements that measure belief (I 
believe further improvement of my [paretic] arm and hand is possible), confidence (I feel 
confident to do what I need to do to use my [paretic] arm and hand in everyday tasks); and 
motivation (I want to be able to use my [paretic] arm and hand more in everyday tasks). The 
individual statements are measured using a 4-point Likert Scale (strongly agree, slightly agree, 
slightly disagree, and strongly disagree).  
4.3.2 Additional study assessments 
The Action Research Arm Test (ARAT) was used to measure UL capacity. The ARAT is a valid 
and reliable measure of UL capacity in adults with UL paresis.40-43 The ARAT is a 19-item 
assessment of grasp, grip, pinch, and gross motor function. Individual items are scored using a 0-
3 ordinal scale (0= unable to complete the task, 1= partially performed, 2= task completed but 
with abnormal movement pattern or > 5 seconds, and 3= performed with normal movement in < 
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5 seconds). Individual item scores are summed, and the final score ranges from 0-57, with higher 
scores indicating better motor function. Paretic UL strength was quantified using the SAFE 
(shoulder abduction, finger extension) score.44 Cognitive function was screened using The 
Montreal Cognitive Assessment (MoCA).45 The MoCA assesses most cognitive impairment 
domains commonly observed in cerebrovascular disease46 and is more sensitive to change 
compared to the Mini Mental Status Exam.46 Participant demographics were collected via 
questionnaire.  
4.3.3 Statistical analysis 
All statistical analyses were completed in R (version 3.3.2),47 an open source statistical 
computing program. Individual change in UL performance over the 12-week study period was 
tested using hierarchical linear modeling (HLM). HLM is an extension of traditional regression 
analysis and models individual intercepts and slopes over time in addition to modeling potential 
moderators of the intercepts and slopes.48,49 Group level intercepts and slopes are derived from 
the individual intercepts and slopes for each accelerometer variable. HLM is the preferred 
method for these data given it does not require the same number of assessments across 
participants and can account for missing data,48,49 thereby including participants with varying 
assessment sessions in the analysis. Our dependent variable was change over time (slope values) 
for each accelerometer variable. The week 2 assessment was the baseline assessment for all 
accelerometer variables and potential moderators of UL performance over time.   
 
First, we analyzed change in UL performance by testing growth curves across the entire sample 
with individual change trajectories nested within each participant (Model 1, primary purpose). 
All nested models were tested using 2 goodness of fit tests to identify the best-fit model. When 
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necessary (e.g. violation of normality assumption), inferences were confirmed via bootstrap 
analysis. Using Model 1, we then tested for potential moderators of UL performance over time 
(secondary purpose). Individual belief, confidence, and motivation were introduced separately 
into the initial model to test for their potential moderating effects on both the intercept and slopes 
for all accelerometer variables. Participants were dichotomized into two categories (dummy 
coded), based off their responses on the 4-point Likert scale: strongly agree (group 1) and 
slightly agree/slightly disagree/strongly disagree (group 2). The decision to dichotomize this 
scale was two-fold. First, participants who “strongly agree” to these questions are considered to 
have high, unwavering belief, confidence and motivation to use their paretic UL in daily life. 
Clinicians would likely not prioritize improving any of these factors with their interventions. 
Participants in the second category (slightly agree/slightly or strongly disagree), however, lack 
varying degrees of surety in their belief, confidence, and motivation. Any of these responses 
could potentially merit intervention in the clinic. The groups were dummy coded and those who 
indicated they slightly agreed/slightly or strongly disagreed (group 2) served as the reference 
group in each model.   
 
An additional moderator of interest was baseline UL capacity (week 2 ARAT score). Baseline 
ARAT scores were grand mean centered and evaluated for their potential moderating effect on 
both the intercepts and slopes (ARAT x time interaction). The significance level for all HLM 
models was set to α < 0.01 due to multiple predictors across four variables. All moderators were 
tested separately, however, the more stringent p value was applied to reduce the likelihood of a 
Type I error.   
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Lastly, we tested for a relationship between the total number of self-perceived barriers to 
recovery and UL performance using Spearman’s rank-order correlations (third purpose). The 
total self-perceived barriers reflects the total number of barriers identified at each assessment. 
We analyzed the relationship between the use ratio and self-perceived barriers at weeks 2 and 12. 
The significance level for correlation analyses was set at α < 0.05. 
 
Visual displays of second-by-second data from the complete 24-hour recording period were 
examined using density plots.31 These density plots display the magnitude ratio (x-axis) and the 
bilateral magnitude (y-axis) for each assessment. Example density plots for healthy, 
neurologically intact adults (figure 3, Hayward et al50; figure 1, Bailey et al31) display several 
key features to consider when interpreting density plots from adults with UL paresis. First, the 
density plots from healthy adults are symmetrical, indicating both UL are active nearly the same 
amount over a 24-hour period. The rounded, bowl-like shape indicates most UL activity is of low 
intensity. The blue points towards the outer rims of the bowl indicate unilateral UL movement 
(e.g. one hand is stirring a bowl while the other stabilizes). A center peak represents higher 
bilateral magnitude values, or more intense UL activity. The color change represents overall 
frequency of UL movement, with warmer colors indicating increased activity and cooler colors 
(blue) indicating less frequent UL activity. The color change in the center of the plot indicates 
majority of UL movement in a 24-hour period is bilateral (magnitude ratio=0) and at low 
intensity levels (low bilateral magnitude value). The small, individual color bars on both sides of 
the plot represent unilateral UL movement. These characteristics are stable across neurologically 
intact, community-dwelling adults.31      
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4.4 Results 
Twenty-nine of the 32 enrolled participants had available data for this analysis. The three 
excluded participants were a result of screen failure, withdrawal prior to completing the week 2 
assessment, and inability to return accelerometers after each assessment. Table 1 presents key 
participant demographics. As expected, the majority of the sample received rehabilitation 
services across all 12 weeks, with 83% admitted to an inpatient rehabilitation facility at the week 
2 assessment. All participants were independent with basic activities of daily living prior to their 
stroke. At week 2, a large percentage of the sample strongly agreed further improvement of their 
UL was possible (belief, 87%) and were confident (83%) and motivated (93%) to use their UL in 
everyday tasks and these numbers stayed high over the duration of the study (Chapter 3). Seven 
participants dropped out of the study between weeks 2 and 12, due to self-selected withdrawal 
(n=2), second stroke (n=1), fatal cancer diagnosis (n=1), fall resulting in fractured UL (n=1), and 
decline in medical status (n=2). 
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Table 4.1 Participant demographics 
 Total sample (n=29) 
Age (years) 68.7 ± 9.9 
Gender 11 F, 18 M 
Race 
23 Caucasian 
5 African American 
1 Asian/ Pacific Islander 
Stroke type 29 ischemic  
Stroke location 
16 cortical 
11 subcortical 
1 cortical & subcortical 
1 posterior circulation/cerebellar 
Affected side 19 L, 10 R 
Concordance, n (%)a 11 (38%) 
Prior working status 
20 not working 
9 working at least part-time 
% Independent with ADL prior to stroke 100% 
% Living alone prior to stroke 17% 
Self-reported comorbidities, median (range)b 2 (0,4) 
% Receiving rehabilitation services 
Week 2 (n=29) 
Week 4 (n=26) 
Week 6 (n=25) 
Week 8 (n=23) 
Week 12 (n=22) 
 
90% 
77% 
68% 
70% 
59% 
% Admitted to rehabilitation hospital at week 2  83% 
Week 2 Values  
Hours of usec 2.82 ± 1.8 
Use Ratiod 0.52 ± 0.26 
Magnitude Ratioe -4.5 ± 2.9 
Bilateral Magnitudef 72.5 ± 16.9 
Belief (% who strongly agree) 87% 
Confidence (% who strongly agree) 83% 
Motivation (% who strongly agree) 93% 
Barriers per participantg  3.4 ± 2.7 
ARATh 25.4 ± 20.8 
SAFE scorei 5.2 ± 3.4 
MoCA score, median (range)j 22 (11, 29) 
Values are mean ± SD unless otherwise indicated 
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a Dominant limb=paretic limb 
b Median number of self-reported comorbidities per participant 
c Total hours the paretic UL was active during the recording period (referent values: 9.1 
hrs/dominant UL, 8.6 hrs/nondominant UL) 
d Hours of the paretic UL divided by hours of nonparetic limb (referent value: 0.95 ± 0.06) 
e Contribution of each limb to an activity for every second of data, 0 indicates equal contribution, 
negative values indicate greater nonparetic UL movement (referent value= -0.1) 
f Intensity of movement, higher values=greater intensity (referent value=136) 
g Out of 13 possible barriers 
h ARAT=Action Research Arm Test, scores range from 0-57, higher values=better function 
i SAFE=Shoulder abduction, finger extension, calculated using the Medical Research Council 
muscle grade scores, scored 0-10 where 10=no strength deficits; participants were enrolled, on 
average, 6.6 ± 3.1 days after stroke  
j MoCA= Montreal Cognitive Assessment, scored 0-30, lower score may also reflect fatigue and 
communication impairments 
 
 
 
There was a significant improvement across all four accelerometer variables over the first 12 
weeks post-stroke (purpose 1). Section I of Table 2 reports estimated slope values for the entire 
sample. These slope estimates represent rate of change per two weeks for the study duration (e.g. 
participants, on average, increased paretic hours of use by .17 hours, or approximately 10 
minutes, every two weeks). Figure 1 presents individual change profiles (spaghetti plots) for 
each accelerometer variable. Despite overall group improvement, UL performance for the 
majority of participants was below referent values over the duration of the study. There was a 
high degree of variability in UL performance across participants for all four accelerometer 
variables, with some participants fluctuating between weeks, some steadily increasing, and some 
demonstrating little to no increase in UL performance. 
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Table 4.2: Values are slope estimate ± SE 
 
**p < 0.001; *p < 0.01  
aSlope estimate for entire sample; significance indicates significantly different from zero 
bReference group=participants who slightly agreed, slightly disagreed, or strongly disagreed 
cParticipants who strongly agreed; slope estimate is modifier x time interaction; slope value is 
with respect to the reference group (e.g. slope estimate for reference group for belief x hours of 
use is 0.16, slope for those who strongly agreed is 0.16 + 0.01 = 0.17); if significant here, slope 
is significantly different from the reference group 
dSlope estimate for participants at the grand mean (25.4 points), significance indicates 
significantly different from zero. 
eBaseline ARAT x time interaction; estimate for every 1 point increase above the grand mean 
(i.e. the ARAT x hours of use slope is attenuated -0.001 for every point above the grand 
mean);significant effect here indicates that the slope changes significantly with changes in 
baseline ARAT
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Figure 4.1 Change profiles for every participant (spaghetti plots). Each line represents a study 
participant with the thick black line representing the mean  SE shading. The dashed lines 
represent referent values from a healthy, community dwelling adult population. For hours of use, 
the dashed red line represents referent hours for the dominant UL and the blue line represents 
referent values for the nondominant UL. 
 
 
Belief, confidence, and motivation did not significantly modify UL performance over the first 12 
weeks post-stroke (Table 2, section II, purpose 2). Compared to the reference group (i.e. those 
who slightly agreed, slightly or strongly disagreed), participants who strongly agreed further 
improvement of their paretic UL was possible (belief), and were both confident and motivated to 
use their paretic UL did not demonstrate greater change over time. The single, moderating effect 
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of motivation on the bilateral magnitude is notable, but should be interpreted with caution given 
the lack of moderating effect on the other accelerometer variables. Figure 2 visually displays the 
predicted slope values for the confidence by time interaction. There was no difference in rate of 
change over time (slope value) in participants who strongly agreed compared to those who 
slightly agreed or disagreed (reference group). Belief, confidence, and motivation did not 
significantly modify the intercepts of any accelerometer variable. 
 
 
Figure 4.2 Predicted slopes for confidence x time interaction. The black line represents the 
reference group (participants who slightly agreed, slightly disagreed, or strongly disagreed) and 
the red line represents participants who strongly agreed. Participants who strongly agreed did not 
differ from the reference group in rate of change over time. 
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There was a single, significant interaction between baseline ARAT and time for the magnitude 
ratio (Table 2, section III). The significant interaction for the magnitude ratio indicates that for 
every one-point increment above the grand mean, the slope is attenuated by 0.007. There was not 
a significant interaction between baseline ARAT and time for the remaining accelerometer 
variables. The significant slope at the grand mean indicates that participants who were at the 
grand mean (25.4 points) had a significant change over time. Baseline ARAT significantly 
modified the intercept for hours of use (intercept= 3.16 ± .02, modified by 0.06 ± .01, p< .001), 
use ratio (intercept=0.57 ± .02, modified by 0.01 ± .001, p<.001), magnitude ratio (intercept=-
3.90 ± .28, modified by 0.12 ± .01, p<.001), and the bilateral magnitude (intercept= 77.3 ± 2.9, 
modified by 0.63 ± .14, p<.001). This significant intercept indicates that for every point increase 
in baseline ARAT, the intercept increased by the modified value listed above (e.g. hours 
intercept increased by .02 hours for every point above the grand mean).    
 
For illustrative purposes, Figure 3 presents individual data for the entire sample grouped by 
baseline ARAT score. Participants were categorized into mild (ARAT between 46-57 points), 
moderate (ARAT between 20-45 points), or severe (ARAT between 0-19 points) UL capacity 
levels for better visualization. Both the intercept and attenuating slope estimates are visually 
represented in Figure 3. Overall, participants with higher UL capacity started with greater UL 
performance (intercepts) but demonstrated less change in UL performance (slopes), compared to 
those with less UL capacity (lower ARAT scores). 
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Figure 4.3 Individual change profiles by week 2 ARAT score. The dashed lines represent 
referent values. For hours of use, the black line represents the dominant UL and the gray line 
represents the nondominant UL. Participants with limited UL capacity at week 2 (low ARAT 
score) demonstrated greater change compared to participants with mild UL paresis.   
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There was a significant, moderate, negative relationship between total self-perceived barriers and 
UL performance at week 2 (rs = -0.45, p=0.01, third purpose). This relationship declined by week 
12 (rs = -0.29, p=0.19), indicating total self-perceived barriers to UL recovery were associated 
with UL performance early after stroke, but not later. 
 
To better visualize changes in UL performance over time, Figure 4 presents density plots from 
three study participants, each with varying degrees of UL capacity at week 2. Participant #1 
(figure 4A) had severe UL paresis at week 2 (ARAT= 0 points), but consistently improved in 
both UL capacity and UL performance across the 12-week study period. Compared to week 2, 
the improved symmetry of the plot indicates an overall increase in paretic UL movement and the 
color change indicates increased overall UL activity (week 12). Participant #2 had moderate UL 
paresis at week 2 (ARAT =24) and increased UL performance between weeks 2 and 12. Similar 
to participant #1, participant #2 increased paretic UL performance (symmetry) and overall UL 
activity (color change) over the study period. Participant #2 demonstrated increased intensity of 
UL movement (bilateral magnitude, center peak) over the study period as well. Lastly, 
participant #3 had mild UL paresis (ARAT = 54). Their paretic UL performance was closer to 
normal, compared to the other participants, at week 2 (less asymmetry), and fell within normal 
range by week 12. 
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Figure 4.4 Examples of individual density plots. Density plots show UL activity for both upper 
limbs, for every second of data. The magnitude ratio, which quantifies the contribution of each 
limb to an activity, is on the x-axis. The y-axis represents the intensity of UL activity (bilateral 
magnitude). At week 2, participant 1 (Fig. 4A) had severe UL paresis, participant 2 (Fig. 4B) had 
moderate UL paresis, and participant 3 (Fig. 4C) had mild UL paresis. Across all three 
participants, there was an increase in UL performance from week 2 to week 12, as observed in 
the improved symmetry, appearance or increase of the center peak (bilateral magnitude), and 
improved overall frequency of UL activity (color change). For all three participants, the majority 
of UL activity occurred bilaterally (magnitude ratio value of 0) and of low intensity, consistent 
with healthy, neurologically intact adults. 
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4.5 Discussion 
To our knowledge, this is the first study to examine the natural trajectory of sensor-measured UL 
performance early after a stroke and characterize the relationship between psychosocial factors, 
self-perceived barriers, and UL performance during the period of time when majority of UL 
motor recovery occurs. Our results show that UL performance can improve early after a stroke. It 
is well-established UL impairment and capacity spontaneously improve after stroke,22,23,51 to 
varying degrees, and these are the first results to suggest this is also true for sensor-measured UL 
performance. This increase in UL performance is not moderated by individual belief, confidence, 
and motivation over the first 12 weeks post-stroke. Our results also showed a moderate, negative 
relationship between self-perceived barriers and UL performance (use ratio) 2-weeks after a 
stroke. By week 12, this relationship weakens. Together, these findings provide novel insight 
into the interconnections of UL performance in daily life and the psychosocial factors that may 
underscore improvements early after a stroke. 
 
The most salient finding was that UL performance increased early after a stroke, which is in 
contrast to previous work in chronic stroke survivors.18,20 The participants who demonstrated the 
greatest increase in UL performance were more impaired at week 2 (low ARAT scores, low 
performance values). These participants had more room to improve, compared to participants 
who were mildly impaired. The increase in UL performance, however, is modest over the 12 
weeks, and the group change was below referent values across all four accelerometer variables. 
Participants likely had variable UL use prior to their stroke. While ratio values are consistent in 
healthy adults, there is a wide range of total hours of UL use and intensity of movement.30,31 
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Improvements in UL performance after a stroke, therefore, may be related to pre-stroke activity 
levels.  
 
As expected, there was a high degree of variability in the change profiles of participants. This 
mirrors the well-documented variability in the recovery of UL impairment and capacity.52-54  
Some participants demonstrated a steady, positive increase over the duration of the study while 
some were more variable between weeks, and others did not change or slightly worsened. The 
degree of heterogeneity varied across the four accelerometer variables. This variability is likely 
influenced by biological, personal, environmental, and compensatory factors. Future studies 
could explore these factors in greater detail to possibly develop a predictive algorithm for UL 
performance, similar to the PREP2 algorithm for UL impairment outcomes.51 To date, the 
prognostic indicators of UL performance are relatively unexplored, leaving the field vulnerable 
to developing a uniform, one-size-fits-all intervention.  
 
There are likely several hypotheses as to why individual belief, confidence, and motivation did 
not modify UL performance over the first 12 weeks post-stroke. The lack of moderating effect is 
likely a result of very high levels of belief, confidence, and motivation across the study duration 
(Chapter 3). More than 80% of the sample strongly agreed they were motivated to use their 
paretic UL in daily life at every assessment session. In the event where participants did not 
strongly agree to these questions, they often slightly agreed. This is an intriguing finding, given 
the current push to incorporate motivation and confidence into clinical interventions.29,55 Early 
after a stroke, it appears these factors are very high and may not merit direct intervention until 
much later (≥ 6 months) in the recovery process. Efficacy expectations are vulnerable to failures, 
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level of task difficulty, and incentives to perform, all of which vary over time and 
circumstance.27 It is reasonable to presume these factors are high early after stroke because most 
survivors possess a strong desire to return to pre-stroke abilities and are willing to engage in 
rehabilitation efforts as a means to meet their recovery goals. Over months and years, belief, 
confidence, and motivation may decline and thus, become more appropriate therapy targets. 
 
Instead, the moderate, negative relationship between self-perceived barriers to recovery and UL 
performance may be an early target of clinical intervention. In-clinic interventions could aim to 
reduce self-perceived barriers that may limit UL performance. Some barriers are appropriate 
clinical targets while some are outside the scope of direct therapy intervention. However, 
addressing barriers, whether through an acknowledgement or a controlled intervention such as 
strategy training56 could help participants increase UL use in daily life.  
 
Several limitations influence the interpretation of these data. The small sample size limits 
generalizability. A larger study, quantifying UL performance over 24-weeks, is currently 
underway to verify these findings. This larger, longer study will allow advanced analyses to test 
for non-linear change in UL performance over a 24 week period. Additionally, belief, 
confidence, and motivation are complex constructs and the survey used in this study was not 
capable of quantifying every aspect of these factors. Currently, there are no validated UL specific 
assessments that probe these factors in-depth. The survey used here was specific to the paretic 
UL, an important detail given that belief, confidence, and motivation are often situation specific 
and vary across tasks.57 Future research could explore individual belief, confidence, and 
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motivation using a mixed methods approach to dissect the different components of these broad 
constructs. 
4.5.1 Conclusions 
Upper limb performance can improve early after a stroke. The participants who changed the 
most had limited UL capacity at week 2 (low baseline ARAT). Participants with higher UL 
capacity (high baseline ARAT scores) started with higher values, compared to those with limited 
UL capacity, and had a narrower range for improvement. The lack of moderating effect of 
individual belief, confidence, and motivation on UL performance suggests improving these 
factors may matter less early after stroke. These factors may vary or decline with increased time 
and personal circumstance. Early after stroke, clinical interventions could address self-perceived 
barriers to UL recovery in effort to increase overall UL performance in daily life. Understanding 
the time course and factors influencing UL performance will ultimately lead to a more integrated 
approach for optimizing UL performance outcomes, a top priority for people post-stroke. 
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5.1 Major Findings 
In Chapter 2, we tested the assumption that improved UL capacity translates to increased UL 
performance in daily life in a chronic stroke cohort (≥ 6 months). We hypothesized that 
individuals with significant UL capacity gains would demonstrate increased UL performance. 
Additionally, we hypothesized there would be no dose-response relationship to UL performance 
in daily life and that concordance (dominant UL = paretic UL) would not modify UL 
performance. Contrary to our first hypothesis, we found that improved UL capacity does not 
translate to increased UL performance in daily life. There was no dose-response relationship to 
UL performance. Lastly, concordance did not moderate UL performance in daily life. Three 
additional moderators (stroke chronicity, baseline UL capacity, and independence with activities 
of daily living), previously shown to moderate UL performance at a single time point, did not 
moderate change in UL performance over time. The lack of improved UL performance in daily 
life was observed at the group and individual level. Indeed, across all 78 participants, not one 
participant improved their UL performance on two or more accelerometry-derived variables. 
These somewhat surprising results led to several new questions that we explored in Chapters 3 
and 4. 
 
In Chapter 3, we examined how psychosocial factors evolve over the first 24 weeks, or 6 months, 
post-stroke. The three psychosocial factors examined were belief further improvement of the 
paretic UL was possible, confidence, and motivation to use the paretic UL in everyday activities. 
We hypothesized that belief, confidence, and motivation would be high immediately after stroke 
and persist over the 24-week study period. Additionally, we quantified the total number of self-
perceived barriers to UL recovery over the same 24-week period. We posited that the total 
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number of self-perceived barriers to UL recovery would be highest immediately after stroke and 
decline over 24 weeks. Our third hypothesis was that depressive symptomatology (CES-D) and 
cognitive impairment (MoCA) would have a negative association with belief, confidence, and 
motivation. Our first hypothesis was supported. Our results showed a remarkably high level of 
belief further improvement of the paretic UL was possible, and confidence and motivation to use 
the paretic UL in everyday activities across the 24-week study period. Very few participants 
indicated low levels of belief, confidence, and motivation at any assessment session. The second 
and third hypotheses were not supported. There was not a significant difference in the total self-
perceived barriers to UL recovery between weeks 2 and 24 and there was no relationship 
between depressive symptomatology, cognitive function, and belief, confidence, and motivation.  
 
In Chapter 4, we characterized the natural trajectory of UL performance over the first 12 weeks 
post-stroke. We then examined if belief, confidence, and motivation significantly moderated UL 
performance over the 12 week period. Lastly, we explored the relationship between self-
perceived barriers and UL performance (use ratio). First, we hypothesized that UL performance 
would significantly increase over the first 12 weeks. Second, we posited that belief, confidence, 
and motivation would significantly moderate UL performance in daily life. Our third hypothesis 
was that a greater number of self-perceived barriers would result in less UL use in daily life 
(negative association). Our first hypothesis was supported. We found that upper limb 
performance significantly improved early after a stroke (≤ 12 weeks). Contrary to our second 
hypothesis, belief, confidence, and motivation did not moderate UL performance over the first 12 
weeks post-stroke. Our third hypothesis was supported, but only at week 2. We found a 
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moderate, negative relationship between total number of self-perceived barriers to UL recovery 
and the use ratio at Week 2, but this relationship did not persist at Week 12. 
5.2 Limitations 
The primary, shared limitation across studies is the sample size. A discussion of the limitations 
associated with sample size, accelerometry, and quantifying belief, confidence, and motivation is 
included in this section. A more detailed discussion of the specific limitations associated with 
each study is included at the end of each chapter. 
 
The small sample size for each study limits the generalizability of these results. In Chapter 2, the 
sample size (n=78) is consistent with a moderately sized clinical trial in stroke rehabilitation. The 
moderate sample size and corroborating cross-sectional data from other research groups1,2 aids 
with the generalizability of our results. We recruited a smaller cohort for the studies reported in 
Chapters 3 and 4 due to the observational, exploratory design. This smaller cohort, however, 
limits the generalizability of these results as well. A larger study is required prior to extending 
these findings to the UL stroke rehabilitation community at large. Conveniently, a larger study 
(n=100) is currently underway to validate the findings reported in Chapters 3 and 4.  
 
Accelerometers are valid and reliable instruments for quantifying UL performance3-8 but are not 
without limitations. Indeed, accelerometers cannot distinguish between activities with similar 
kinematic profiles (e.g. chopping vegetables or typing on a computer), or the purpose of 
activities, and do not provide information about the quality (i.e. presence or absence of 
compensatory movement patterns) of UL movement. Accelerometers record all UL movement, 
including arm swing associated with walking and unintentional UL movement. Previous work 
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has unsuccessfully attempted to distinguish between intentional and unintentional UL 
movement9-11 and also failed to reliably identify accelerations associated with walking in adults 
with stroke.12 The recording of unintentional UL movement and arm swing while walking, if 
anything, results in a slight overestimation of UL movement in daily life. Given that the majority 
of participants in these studies were well below referent values, it is unlikely that even a slight 
overestimation positively biased our results. 
 
Belief, confidence, and motivation are complex constructs and the results reported in Chapters 3 
and 4 should be interpreted with caution. These studies were not designed to probe the full extent 
of each construct. It is recommended that future research explore these constructs in more detail 
in order to make definitive conclusions regarding the potential role of belief, confidence, and 
motivation in UL performance recovery. Currently, the field is limited by a lack of standardized 
psychosocial assessments that are specific to UL performance after stroke. The Stroke Self-
Efficacy Scale,13 for example, is a general measure that emphasizes walking and life roles, not 
UL performance. Self-efficacy, and its related components, are situation specific and often vary 
across individual tasks.14 This warrants the development of an UL-specific outcome measure to 
explore the full extent of belief, confidence, and motivation in addition to other potential 
psychosocial factors of interest (e.g. self-regulation). 
5.3 Innovation, significance and impact 
These studies are significant for several reasons. First, Chapter 2 includes the first study to show 
that what someone is capable of doing with their paretic UL in the clinic does not translate to 
increased UL performance in daily life in the chronic phase of stroke recovery. The failure to 
increase UL performance in daily life at ≥ 6 months post-stroke is likely due to several factors. 
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First, recovery of UL impairment and capacity has plateaued by 6 months post-stroke. 
Individuals have likely established new habits or routines that may exclude the paretic UL, 
which contributes to the learned non-use phenomenon.15 The lack of rehabilitation services in the 
chronic phase of recovery reduces access to healthcare providers who may assist with addressing 
barriers to UL performance. Lastly, the changes observed in UL capacity may not have been 
sufficient to increase UL performance in daily life. Indeed, there may be a specific threshold for 
UL capacity to exceed in order to increase UL performance in daily life. 
 
Chapter 3 includes the first study to characterize the evolution of belief, confidence, and 
motivation to use the paretic UL in daily life during the early weeks and months post-stroke. 
Prior to this study, cross-sectional data in cohorts 4-7 years post-stroke provided our limited 
knowledge of these psychosocial factors and self-perceived barriers to UL recovery.16-18 
Quantifying these factors across the early weeks after stroke captured their inherent dynamic 
nature during the time when majority of stroke recovery occurs and rehabilitation services are 
delivered.19  
 
This thesis includes the first study to map the natural trajectory of sensor-measured UL 
performance over the first 12 weeks post-stroke. This is significant for several reasons. First, 
mapping the natural trajectory of UL performance during the same period of time when the 
majority of recovery of UL impairment and capacity occurs affords future opportunities to 
compare the recovery trajectories of these three domains. Second, this was the first study to show 
that UL performance in daily life naturally improves during the period of time when UL capacity 
and impairment improvement occurs. Lastly, to our knowledge, this was the first study to test the 
112 
 
moderating role of three psychosocial factors on UL performance. In the wake of discovering 
that improved UL capacity does not translate to increased UL performance, psychosocial factors, 
such as confidence and motivation, emerged as possible clinical targets to improve UL use in 
daily life. This was the first study to test if these factors moderated UL performance in daily life. 
The results reported in Chapter 4 suggest that belief, confidence, and motivation may not be 
appropriate mechanisms to target when trying to increase UL performance early after stroke. 
This begins what will likely be a long, informative pursuit of understanding how UL use in daily 
life changes over the early weeks and months post-stroke and what factors may moderate this 
change. 
 
Together, the results from Chapters 2, 3, and 4 are important for the stroke rehabilitation 
community. Assuming improvements in what someone is capable of doing in the controlled 
clinical environment is no indication of what that individual will actually do at home. The 
purpose of rehabilitation is to improve performance in daily life. Until now, UL performance was 
often a secondary outcome, quantified via self-report. The results reported here make a 
compelling case for including UL performance as a primary outcome, quantified with a direct 
measure (i.e. sensors). Increasing UL performance in daily life will likely require a complex 
intervention. Future research can use the results reported in Chapters 2, 3, and 4 to help design 
interventions that primarily target UL performance in the early months post-stroke. 
5.4 Future Directions 
There are several implications for future research from the results reported in this thesis. Upper 
limb performance in daily life continues to be a relatively unexplored area, compared to UL 
impairment and capacity.20 To better understand the recovery of UL performance, there are five 
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directions for future research. First, future studies can explore the components of belief, 
confidence, motivation and other factors beyond the motor system that may influence UL 
performance in daily life. Second, future research could explore biomarkers of recovery that 
predict who improves UL performance early after stroke. Third, future interventions can pilot 
novel behavioral techniques to increase UL performance in daily life. Fourth, piloting strategy 
training techniques to reduce self-perceived barriers to UL recovery may be worthwhile. Lastly, 
there are no minimal clinically importance difference (MCID) values for the accelerometry-
derived variables. Future work may want to establish clinically meaningful change scores for the 
accelerometer variables to allow for a more robust interpretation of change over time.  
5.4.1 Components of belief, confidence, and motivation. 
Belief, confidence, and motivation are complex, dynamic constructs. Given the stability of belief 
over several years post-stroke,16,17 perhaps the priority for future studies is exploring the different 
dimensions and sources of motivation and confidence. There are two key sources of 
motivation.21 People are motivated to act by intrinsic sources (e.g. value an activity, personal 
commitment to a goal) or extrinsic sources (e.g. a bribe, fear of being watched or disappointing 
others).21 People who are intrinsically motivated to perform a task have greater interest, 
confidence, persistence, and higher overall vitality over time than those who are extrinsically 
motivated.21-23 It is possible some individuals who are receiving rehabilitation are motivated by 
external sources such as fear of disappointing their therapist/loved ones, obligation, or rewards. 
Other individuals may be intrinsically motivated, or a combination of both. These extrinsic and 
intrinsic sources are not static and therefore will change across the recovery period, making the 
need for well-designed longitudinal studies apparent. Understanding the sources of an 
individual’s motivation after a stroke is important for understanding long-term outcomes. While 
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extrinsic sources of motivation are common, intrinsic sources of motivation lead to better long-
term behavioral outcomes (e.g. medication adherence,24 weight loss maintenance25), persistence, 
and enhanced subjective well-being.21 Similarly, confidence is influenced by many factors, 
namely prior successes and failures with the specific or related tasks.26,27  
 
Quantifying the contributing sources of motivation and confidence will require mixed-methods 
research that queries a large sample of stroke survivors over time. Information from mixed-
methods research will contribute to the development of more robust standardized assessments. 
Additionally, future research could explore the role of self-regulation,21,28,29 outcome 
expectation,29 and perceived control27 in moderating UL performance in daily life. Investigating 
these additional factors as potential moderators of UL performance may help identify other 
salient mechanisms to target with performance-based interventions.   
5.4.2 Biomarkers of recovery 
The recovery of UL impairment and capacity are highly variable across individuals post-stroke. 
30-32 Recent work has identified clinical and neurological biomarkers that predict, with an 
exceptionally high degree of accuracy, the expected recovery of UL capacity post stroke.33-35 
Together, the individual biomarkers were combined to form a predictive algorithm for the 
recovery of UL functional capacity at 6 months post-stroke. This predictive algorithm improves 
the efficiency of rehabilitation services, identifies the recovery potential of each individual, and 
provides stratification parameters for researchers to help control for the variability in UL 
recovery.35 To date, no research has explored potential predictors for the recovery of UL 
performance. Without this information, researchers and clinicians do not know who will improve 
their UL use in daily life and by how much. This leaves the field vulnerable to implementing a 
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uniform, one-size-fits-all intervention. Future research could explore potential biological (e.g. 
initial UL impairment, apathy), personal (e.g. personality factors), psychosocial (e.g. self-
regulation), and environmental factors (e.g. home environment) that may predict the recovery 
potential of UL performance that will ultimately lead to more individualized, comprehensive 
interventions. 
 5.4.3 Piloting novel behavioral change techniques 
Changing behavior (here, UL performance) in the free-living environment is difficult and likely 
requires novel techniques not currently implemented in routine rehabilitation interventions. The 
few stroke rehabilitation studies designed to improve performance in daily life defaulted to 
educational training or therapist coaching techniques and failed to consistently incorporate 
principles of behavior change such as feedback, social comparisons, and incentives.36  The skill 
transfer package, created as part of constraint-induced UL movement therapy (CIMT), is an 
exception. A skill transfer package includes behavioral components such as a behavioral 
contract, daily logs of UL activity, addressing perceived barriers, phone calls with clinicians 
(accountability), and written homework to help increase UL use in daily life.37 A transfer 
package has previously shown to improve self-reported UL performance in daily life,37 but has 
yet to demonstrate efficacy for improving sensor-measured UL performance. Of note, the 
individualized, intensive task-specific intervention delivered in Chapter 2 included some 
components of a transfer package but failed to increase sensor-measured UL performance. 
Future studies can incorporate principles of behavior change such as feedback, social 
comparison, or incentives to help increase UL performance in daily life in the early months post-
stroke. The high levels of belief, confidence, and motivation early after stroke will be an asset to 
these future UL interventions. 
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A small number of stroke rehabilitation studies have tested feedback as a means to change 
performance. The SIRROWS trial provided feedback on gait speed during inpatient 
rehabilitation. The results showed that feedback about performance, compared to no feedback, 
significantly improved discharge gait speed.38 Two studies are currently underway in Europe 
testing if real-time feedback increases daily UL performance in individuals with stroke using a 
smartphone application.39,40 Exploring the potential role of feedback, delivered in real-time as 
opposed to several days or weeks after wearing the sensors, is a critical next step in UL 
performance research.  
 
Social comparisons are powerful techniques that provides not just feedback about individual 
performance but also how individual performance compares to peer performance.41 Social 
comparison feedback significantly increased the total daily steps in a healthy adult population.42 
For individuals with stroke, real-time feedback could include peer comparison (i.e. feedback 
includes how individual UL performance compared to other individuals receiving therapy at the 
same clinic) to help increase UL use in daily life. Borrowing from behavioral science, future 
research may employ a team approach to help increase UL performance in daily life. The 
individual with stroke can couple with another person (e.g. marital partner, adult child, close 
friend), form a team, and collectively work towards achieving a daily UL performance goal. The 
feedback would include how each team’s UL performance ranks amongst other teams in the 
study or rehabilitation clinic. Social comparison feedback via a team approach has demonstrated 
positive results with weight loss interventions41 and improving overall physical activity43 and 
may also reduce the negative effects of social isolation after a stroke. Additionally, future studies 
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designed to increase UL performance in daily life may want to pilot the use of financial 
incentives to increase UL use, as financial incentives serve as powerful motivators and help 
increase steps per day in adult populations.44,45 
5.4.4 Strategy training to reduce barriers 
Cognitive strategy training techniques may help address the negative relationship between self-
perceived barriers and UL performance reported in Chapter 4. Strategy training interventions use 
meta-cognitive strategies to help individuals observe, assess, and alter behaviors in effort to 
improve participation in everyday life roles.46,47 A key feature of strategy training includes 
teaching individuals to identify barriers to different activities and actively problem solve through 
the identified activity limitations.48 Global strategy training (e.g. “Goal-Plan-Do-Check”) is 
feasible early after stroke48 and can improve outcomes in adults with cognitive impairment.47,48 
Given the significant relationship between self-perceived barriers to UL recovery and UL 
performance at 2 weeks post-stroke, applying global strategy training techniques to reduce self-
perceived barriers in an effort to increase UL use in daily life may be worthwhile. 
5.4.5 Detecting meaningful change with accelerometers 
Detecting a statistically significant change in the accelerometry-derived variables is likely 
different from a clinically meaningful change. The minimal clinically important difference 
(MCID) score represents the minimum change score on a measure (here, accelerometry) that is 
detectable by an individual that may lead to an updated treatment plan.49-51 While flawed, the 
MCID score provides helpful information that allows clinicians and researchers to interpret 
change scores as meaningful to individuals. Previous research has established MCID values for 
measures of UL capacity52,53 and UL impairment.54,55 To date, only one study has attempted to 
define an MCID score with accelerometer data, using total activity counts.56 Future work may 
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want to pursue establishing MCID values for the clinically relevant accelerometer variables, such 
as the use ratio and hours of paretic UL use. Establishing the MCID values will help researchers 
and clinicians interpret meaningful individual and group change over time. 
5.5 Conclusions 
The goal of rehabilitation post-stroke is to improve performance in everyday life. The results 
reported in this dissertation suggest that improving performance in everyday life is complex and 
perhaps one of the next big challenges in the stroke rehabilitation field. Increasing UL 
performance in daily life will require novel interventions that extend beyond in-clinic protocols 
that only improve UL capacity. To the field’s benefit, however, are the high levels of belief, 
confidence, and motivation that individuals with stroke possess during the period of time when 
the majority of motor recovery occurs. Future interventions can leverage these high levels to help 
increase UL performance. Together, these results will contribute to the larger discussion and 
provide valuable data for future, larger studies of UL performance. 
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Appendix A 
The figure below provides a visual representation of some of the data reported in Chapter 2 
(Table 2.2). These figures were not included in the publication but visually illustrate the slope 
values for the entire sample, participants with a significant change in UL capacity, and 
participants who were concordant (dominant limb = paretic limb).   
 
Figure A.1 Means ± SD for the use ratio (A), hours of paretic limb use (B), bilateral magnitude 
(C), and median values for the magnitude ratio (D) over the study duration. Dashed lines 
represent referent values. For hours of use, the gray dashed line is the referent value for the 
dominant limb and green dashed line is the referent value for the nondominant limb. There was 
no change in UL performance across the entire sample (black line), participants with a clinically 
meaningful change in UL capacity (red line), and participants who were concordant (blue line).  
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Appendix B 
This was a sub-analysis exploring the potential role of cognition on the reporting of each 
psychosocial factor, depressive symptomatology (CES-D), and overall health state (EuroQol-5D-
3L). The CES-D and EuroQol are two additional self-report measures collected in this study. 
Exploring additional self-report measures affords a more comprehensive evaluation of the 
potential role of cognition on reporting abilities of the sample. 
The submission for publication did not include these figures but they may be of interest to the 
committee given the high prevalence of cognitive impairment after stroke.  
Overall, there were no substantial reporting differences between participants who were 
cognitively intact (MoCA score ≥ 26) or cognitively impaired (MoCA score ≤ 25). Using 
established thresholds, participants who were cognitively impaired are either mildly (MoCA 
score between 19-25 points) or severely impaired (MoCA score < 19 points).  
 
Figure B.1 Belief, confidence, and motivation values at the week 2 assessment by cognitive 
level. The boxplots show median values (solid black line) and interquartile range. The median 
value is 4 (strongly agree) for both groups, with no concerning differences noted. Five 
participants had no cognitive impairment, and 23 participants were considered cognitively 
impaired (mild impairment, n=14; severe impairment, n=9).   
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Figure B.2 Belief, confidence, and motivation values at the week 12 assessment by cognitive 
level. The boxplots show median values (solid black line) and interquartile range. At week 12, 
the median value remains at 4 (strongly agree) for both groups. As expected, cognitive abilities 
improved at week 12 with more participants presenting with no impairment (n=8). Of those who 
were cognitively impaired, the majority were mildly impaired (n=12), with an overall decrease in 
the number of severely impaired participants (n=2).  
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Figure B.3 Belief, confidence, and motivation values at the week 24 assessment by cognitive 
level. The boxplots show median values (solid black line) and interquartile range. The median 
value remains at 4 (strongly agree) with no observable differences that would suggest a reporting 
bias in the cognitively impaired group. Cognitive function continued to improve by week 24 with 
more participants presenting with no impairment (n=9). Of those who were cognitively impaired, 
the majority were mildly impaired (n=9) compared to severely impaired (n=3).  
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Figure B.4 Total score on the Centers for Epidemiological Studies Depression Scale (CES-D) at 
weeks 2, 12, and 24 by cognitive level. Total scores range from 0-60, with higher scores 
indicating the presence of more depressive symptomatology. A total score > 16 points may 
indicate a depressive episode. Here, the median value for both cognitive groups was below the 
16-point threshold, indicating low depressive symptoms in our sample. There is no clear 
evidence that cognitive function biased the reporting of depressive symptomatology.  
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Figure B.5 Participant self-reported health state (EuroQol-5D-3L1) by cognitive level at weeks 
2, 12, and 24. Self-reported health state scores range from 0-100, with higher scores indicating a 
better overall health state. There is no evidence that cognitive abilities biased the reporting of 
overall health state across weeks 2, 12, and 24.  
   
 
 
 
 
 
 
 
                                                 
1 Brooks R, Group E. EuroQol: the current state of play. Health policy. 1996;37(1):53-72; 
 
  Group TE. EuroQol-a new facility for the measurement of health-related quality of life. Health policy. 
1990;16(3):199-208. 
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Appendix C 
This study fulfilled the degree requirement for the Masters of Science in Clinical Investigation 
(MSCI) degree. These results show a high degree of variability and inconsistency between self-
reported and sensor-measured UL performance after stroke (Chapter 1) and may be of interest to 
the committee.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study has been published: 
Waddell KJ. Lang CE. Comparison of self-report versus sensor-based methods for measuring the 
amount of upper limb activity outside the clinic. Archives of Physical Medicine and 
Rehabilitation, September 2018; 99(9): 1913-1916. 
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C.1 Abstract 
Objective: To compare self-reported with sensor-measured upper limb (UL) performance in 
daily life for individuals with chronic (≥ 6 months), UL paresis post-stroke. Design: Secondary 
analysis of 64 participants enrolled in a Phase II randomized, parallel, dose-response UL 
movement trial. This analysis compared the accuracy and consistency between self-reported UL 
performance and sensor-measured UL performance at baseline and immediately post an 8-week 
intensive UL task-specific intervention. Setting: Outpatient rehabilitation. Participants: 
Community dwelling individuals with chronic (≥ 6 months) UL paresis post-stroke. Main 
outcome measures: Motor Activity Log- Amount of Use Scale and the sensor-derived use ratio 
from wrist-worn accelerometers. Results: There was a high degree of variability between self-
reported UL performance and the sensor derived use ratio. Using sensor-based values as a 
reference, three distinct categories were identified: accurate reporters (reporting difference ± 
0.1), over reporters (difference > 0.1), and under reporters (difference < -0.1).  Five of 64 
participants accurately self-reported UL performance both pre and post-intervention. Over half of 
participants (52%) switched categories from pre-to post-intervention (e.g. moved from under 
reporting pre-intervention to over reporting post-intervention).  For the consistent reporters, no 
participant characteristics were found to influence whether someone over- or under-reported 
performance compared to sensor-based assessment. Conclusions: Participants did not 
consistently or accurately self-report UL performance when compared to the sensor-derived use 
ratio. While self-report and sensor-based assessments are moderately associated and appear 
similar conceptually, these results suggest self-reported UL performance is often not consistent 
with sensor-measured performance and the measures cannot be used interchangeably. 
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C.2 Introduction 
Individuals with stroke are referred for rehabilitation services to improve performance in daily 
life. Performance, defined as what a person actually does in his/her current environment, outside 
of a rehabilitation clinic or laboratory,1 is difficult to measure for the upper limb (UL). 
Performance is most commonly quantified by amount, with other aspects (e.g. quality or 
efficiency) being more difficult to measure during everyday life.  Researchers must choose 
between self-report measures of UL performance, which provide critical information about 
patient perception of abilities but are subject to inherent biases such as social desirability and 
recall bias,2,3 or sensor-based methods, such as accelerometry. Accelerometry is a valid, reliable, 
quantitative measure of UL performance in daily life4,5 and is not subject to the same biases as 
self-report measures, but cannot determine the specific activities someone performs and will 
capture functional as well as non-functional movements. 
  
Of note, a recent physical activity review indicates self-report and sensor quantifications of 
physical activity can vary widely and unsystematically, with correlations ranging from -0.7 to 0.7 
across studies.6 The purpose of this brief report, therefore, was to compare self-report and 
sensor-based measures of UL performance in daily life in a clinical trial cohort of persons with 
chronic stroke. While self-report and sensor-based UL performance measures are moderately 
correlated,5 it is critical to know the accuracy and consistency between the two measures. 
C.3 Methods 
This was a secondary analysis from a Phase II, randomized, parallel, dose-response trial of 
intensive, task-specific UL motor training (see7 for comprehensive assessment battery).7 Data 
from the baseline and post-intervention assessment time points were used for this analysis. The 
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trial was approved by the Washington University Human Research Protection Office and all 
participants provided informed consent.  
C.3.1 Assessments 
Our sensor-based measure of UL performance in daily life was derived from bilateral, wrist-
worn accelerometers (wGT3X+, Actigraph, Pensacola, FL). Accelerometers record movement in 
terms of acceleration across three axes in activity counts. Participants wore the accelerometers 
for 24 hours pre-intervention and again for 24 hours post-intervention during all daily activities, 
including bathing and walking.8 The variable of interest for this comparison was the use ratio, an 
established metric of UL performance in daily life post-stroke.4,9 The use ratio quantifies the 
amount of time the paretic UL is active relative to the non-paretic UL and ranges from 0-1. A use 
ratio value of 1 indicates both UL were active the same amount of time throughout the recording 
period and a use ratio of 0.5 indicates the paretic limb was active 50% of the time the non-paretic 
UL was active.  Healthy, non-disabled adults have a use ratio value of 0.95 (SD = 0.06).9   
 
The self-report measure of UL performance was the Motor Activity Log (MAL) amount of use 
(AOU) scale.10 Participants reported how much they used the paretic UL across 28 representative 
functional activities, with scores from 0 = did not use the paretic UL to 5= used the paretic UL as 
often as before the stroke. Because the use ratio is near unity and highly consistent in 
neurologically-intact adults, then a score of 3 on the AOU scale (used paretic UL half as much as 
before the stroke) is comparable to a sensor-derived use ratio of 0.5, where the paretic UL is 
active half as much relative to the non-paretic limb, and a use ratio of 1 is analogous to a 5 on the 
MAL.9   
 
134 
 
C.3.2 Statistical Analysis 
Using the sensor-derived use ratio and the final MAL AOU value, correlation analyses were 
completed pre and post-intervention to examine the association between the two measures. Each 
individual’s total MAL AOU values were scaled from 0-1 to match the range of the use ratio. 
The use ratio was subtracted from the individual scaled AOU values at each time point to create 
a difference score. Participants whose difference score was ± 0.1 (±10%) were classified as 
“accurate” reporters. Participants whose difference score was > +0.1 were classified as “over 
reporters” and those whose difference score was < -0.1 were “under reporters.” This 
classification scheme was determined separately for the two time points. 
  
To examine the accuracy and consistency between the two measures, frequencies of the different 
categories were first calculated. Second, consistency of classification was examined by 
computing frequencies of individuals who were in the same category at both time points (e.g. 
accurate at baseline and post-intervention) vs. those who switched categories (e.g. accurate at 
baseline and under-reported post-intervention). And third, of the participants who were 
consistent, we explored characteristics that may explain their classification accuracy. Because of 
small, imbalanced group numbers, 95% confidence intervals of potential exploratory 
characteristics of age, memory (i.e. Short Blessed Test), depressive symptomatology (i.e. Centers 
for Epidemiologic Studies Depression Scale [CES-D]), baseline UL motor capacity (i.e. Action 
Research Arm Test [ARAT] score), and concordance (dominant limb = paretic limb) were 
examined across the three categories. 
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C.4 Results 
Sixty-four of 85 clinical trial participants had available data for this analysis. The 21 excluded 
participants had either accelerometer recording errors, missing self-report data, or withdrew from 
the study. Participant demographics (Table 1) were not different from the large clinical trial 
cohort.7 This cohort of persons with mild to moderate UL paresis was enrolled at similar time 
points post-stroke.8 The MAL-AOU (2.73 ± 0.94) and the use ratio (0.66 ± 0.22) were not 
different from the total cohort.  Consistent with previous reports5, the MAL and use ratio were 
moderately associated at baseline (r=0.31, 95% CI [0.07, 0.51], p = 0.014) and post-intervention 
(r = 0.52, 95% CI [0.32, 0.68], p < 0.001).  
Table C.1 Participant demographics. Values are means ± SD or median (min, max) 
 Entire sample (n=64) 
Age 61.2 ± 11.1 
Gender 22 F, 42 M 
Race  
37 Caucasian 
26 Afr American 
1 Multi-race 
Type of stroke 
47 ischemic 
6 hemorrhagic 
11 unknown  
Months post-stroke 11.5 (6, 180) 
Affected side 35 R, 29 L 
% Concordancea 52%  
% Independent with ADL 81% 
Baseline ARATb score 32 ± 10.9 
Baseline Use Ratio 0.66 ± 0.2 
Baseline MAL AOUc 2.73 ± 0.9 
 
a= Concordance = dominant side is paretic side; value here indicates the percentage of the 
sample who identified their dominant UL as the paretic UL 
b= Action Research Arm Test; scores range from 0-57 points with higher scores indicating more 
normal movement. Here, participants had mild to moderate UL paresis at baseline.  
c= Motor Activity Log, Amount of Use scale; scores range from 0-5 where 0= did not use the 
paretic UL to 5= used the paretic UL as often as before the stroke. 
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The main finding in this study is the high degree of variability between self-reported and sensor 
derived UL performance, as indicated by the difference scores (Figure 1A baseline; Figure 1B 
post-intervention). The majority of participants under-reported their UL performance (negative 
difference scores) at both time points.  
 
Figure C.1 Reporting differences (MAL-Use Ratio) across the sample for (A) baseline and (B) 
post-intervention.  Accurate reporters were defined as a difference value of ± 0.1; under-
reporters were < -0.1 and over-reporters were > 0.1. There was a high degree of variability 
between self-reported and sensor-derived performance at both time points.  
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Thirty-one of 64 participants (48%) were consistent in their category, with the remaining 33 
participants (52%) being inconsistent (i.e. switching categories). Table 2 explores the 31 
consistent reporters, divided into consistently accurate, under-reporting, and over-reporting. Only 
five participants were classified as consistently accurate. In this small sample, we could see no 
differences in age, cognitive function, depressive symptomatology, UL functional capacity, and 
concordance (dominant limb = paretic limb) across categories to explain these reporting 
differences. 
 
Table C.2 Potential modifiers of reporting accuracy across consistent reporters. Values are 
means ± SD (95% CI) or n (%). 
  
Modifier 
Accurate 
(n = 5) 
Under reporters 
(n=24) 
Over reporters 
(n=2) 
Age 63.8 ± 7.3 60.7 ± 10.2 56 ± 11.3 
Cognition 
(Short Blessed Test)a 
3.2 ± 4.1 
(0, 6.8) 
3.4 ± 6.1 
(0.9, 5.8) 
5 ± 7.1 
(0, 14.8) 
Depressive Symptomatology 
(CES-D)b  
11.4 ± 9 
(3.5, 19.3) 
16.5 ± 11.9 
(11.7, 21.3) 
11 ± 9.9 
(0, 24.7) 
UL functional capacity 
(ARAT)c 
33.8 ± 16 
(19.8, 47.8) 
31.4 ± 10.5 
(27.2, 35.6) 
37 ± 1.4 
(35, 38.7) 
Concordanced  (n (%)) 2 (40%) 12 (50%) 2 (100%) 
 
a= Cognitive screen for memory, orientation, and concentration with scores ranging from 0-28; 
lower scores indicate better cognitive function (0-4 = normal cognition) 
b= Center for Epidemiologic Studies Depression Scale; Scores range from 0-60 with higher 
scores indicating greater depressive symptomatology  
c= Action Research Arm Test; Scores range from 0-57 with higher scores indicating better 
function. All individuals across groups had moderate UL paresis. 
d= Concordance is when the dominant limb is the affected, paretic limb 
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C.5 Discussion 
Despite moderate correlations, we found a high degree of variability and inconsistency between 
self-reported and sensor-measured UL performance measures post-stroke. Half of our sample 
consistently reported UL performance from pre to post-intervention, but only five individuals 
accurately reported at both time points. Many UL clinical trials include an outcome measure of 
UL performance in daily life. The high degree of variability and inconsistencies between self-
reported and sensor-measured performance indicate the measures cannot be used 
interchangeably. If a tested intervention is intended to improve self-perceptions of UL 
performance, then a self-report measure is the better choice. If a tested intervention is intended to 
improve actual arm use in daily life, then using a quantitative measure of UL performance is the 
better choice. 
 
The inconsistency across time points seen here is concerning. As with the physical activity 
literature,6 reporting inconsistency could compromise the results of research studies testing the 
efficacy of interventions to improve UL performance post-stroke. If individuals are not 
consistent and/or accurate in their reporting of UL performance, their change scores will contain 
a large degree of error and it will be difficult to draw conclusions about whether or not an UL 
intervention can drive change outside of the clinic or laboratory. 
C.5.1 Limitation 
A key limitation of this brief report is the modest sample size. The sample analyzed cannot 
generate definitive conclusions regarding self-report and sensor-measured UL performance. 
Instead, these data serve to initiate a critical dialogue amongst researchers regarding the most 
appropriate UL performance outcome measure for each individual research study.  
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C.5.2 Conclusions 
While self-report and sensor-based assessments are moderately associated and appear similar 
conceptually,5 these results indicate self-reported UL performance is often not consistent with 
sensor-measured UL performance. It is recommended that clinicians and researchers measure 
outcomes via self-report if improved perception of UL performance is the primary outcome of 
interest and measure outcomes via sensors if improvements in actual UL performance is the 
primary outcome of interest. 
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